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Nanotechnology, a rapidly growing applied science, is expected to have a 
significant impact on almost all industries and all areas of society within the next 
decade. Nanomaterials, defined by the National Nanotechnology Initiative (NNI), 
have at least one dimension in the range of 1-100 nanometers. Due to their small 
size, the properties of nanomaterials may be different from those of their bulk 
substituents, showing unique chemical, physical, optical and electrical properties. 
Nanotechnology involves in creating and applying engineered materials at the 
nanoscale to take advantage of these specific properties. [1]. Potential 
applications of nanomaterials are being investigated in medicine, plastics, 
energy, electronics and aerospace. Obviously, nanotechnology, as “a new 
industrial revolution”,  is expected to have a significant influence on many 
industries and our life in the future [2]. The National Nanotechnology Initiative 
(NNI) estimated nanotechnology could contribute trillion dollars to the U.S. 
economy by 2015, and 2 million people may be working in the nanotechnology 
field by that time [1]. Clearly, nanotechnology will play an important role in the 
world’s future economy.  
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Engineered nanoparticles have already been produced, sold, and used 
commercially in products such as sporting goods, tires, stain-resistant clothing, 
cosmetics, and imaging systems [3]. Sunscreens used in cosmetics containing 
nanoscale titanium dioxide or zinc oxide particles are transparent but effectively 
block ultraviolet rays [4]. Engineered nanomaterials designed to neutralize 
chemical spills are currently available. The number of future applications of 
nanomaterials appears almost limitless.  
Semiconductor-based quantum dots are one type of nanoparticle. Due to 
their small size and a high surface to volume ratio, semiconductor nanoparticles 
have novel physical and chemical properties which make them attractive for 
applications in electronics, optical communications, environmental remediation, 
drug delivery, cancer therapy and biomedical imaging [5, 6]. While organic dyes 
have historically been used in cellular imaging, the broad spectral widths, photo-
bleaching, complex synthetic chemistry, poor water solubility, and high cost of 
manufacturing constitute disadvantages for use of these probes. The use of 
luminescent nanoparticles can overcome some of these problems. The 
photophysical behavior of some luminescent nanoparticles allows fine tuning to 
select for discrete emission and excitation properties and thus may be 
advantageous for a variety of labeling and imaging applications [6]. In vivo 
applications often require that excitation and emission wavelengths are in the 
near-infrared (NIR) range from 700 to 1100 nm due to tissue penetration 
difficulties [7]. Many cadmium- and mercury-containing semiconductor 










Figure 1. Three sizes of CdTe nanoparticle solution under Ultraviolet light   
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 studied, cadmium telluride (CdTe) particles exhibit high photoluminescence 
quantum efficiencies, stable luminescence, and their emission can essentially 
cover the entire spectral range from blue to near infrared [8]. These unique 
properties make CdTe nanoparticles attractive candidates for imaging and many 
other biomedical applications. The toxic potential of these materials may limit 
their application potential, however.  
The fullerenes, a family of carbon allotropes (C60, C70, and C80…C200) 
discovered in 1985, have attracted attention from different science and 
engineering areas, leading to the presentation of the 1996 Nobel Prize to Kroto, 
Smalley and Curl for their identification of these unique molecules. C60 was 
named after Richard Buckminster Fuller as buckminsterfullerene, or the “Bucky 
ball” [9].  Now, C60 and its derivatives are commonly referred to as fullerenes. 
This allotrope of carbon consists of 60 carbon atoms joined together to form a 
cage-like structure (see picture below). C60 is soluble in aromatic solvents (e. g, 
toluene or benzene), but insoluble in water and alcohol [10]. However, C60 can be 
functionalized (e.g., with –OH, -COOH, -NH2) to increase its hydrophilicity. On 
the other hand, nanosized aqueous fullerene aggregates (nano C60 or nC60) can 
be generated by slowly mixing pure C60 in water or through a method involving 
solvent extraction. Some fullerenes have been shown to block human 
immunodeficiency virus (HIV) activity by inhibiting an HIV-associated protease, 
an essential enzyme for viral survival [11]. It was reported that some fullerenes 





                                 Figure 2.  Cage-like structure of fullerene (C60) 
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antitumor activity [14], enzyme inhibition [15, 16], DNA photo cleavage [17, 18], 
and neuroprotective activity via antioxidant actions [19]. At present, fullerenes are 
commercially used in products including fuel cells, semiconductors and product 
coatings, e.g., bowling ball surfaces [1]. 
 
Health Concerns  
Any new technology, before introduction into the market place, needs 
careful evaluation for health risks. Potential adverse effects of synthetic 
nanomaterials on human health and the environment are of concern. Exposures 
to natural airborne nanosized particles have been experienced by humans 
throughout time. Nanosized materials can be generated naturally from 
combustion processses such as forest fires and volcanic eruptions [4]. 
Respiratory diseases caused by coal mine dusts are well known from 
epidemiological  studies and include coal worker’s pneumoconiosis, chronic 
bronchitis, and emphysema [20-22]. There have been a number of papers 
highlighting the potential environmental hazards arising from nanotechnology [3, 
23, 24]. Some nanoparticles appear to be able to distribute, deposit in organ 
systems, penetrate individual cells, and trigger toxic responses. Lam and 
coworkers reported that a suspension of carbon nanotubes (one of the most 
widely used types of nanomaterials) placed directly into mouse lungs caused 
granulomas, lesions that can interfere with gas exchange in the airways [25]. 
Warheit et al.reported that tracheal instillation led to the clustering of immune 
cells around nanotube deposits in the animals’ lungs. At the highest dose 
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studied, 15% of the rats essentially suffocated due to the aggregation of the 
nanotubes and cells and subsequent blockade of the airways [26].  
While a variety of semiconductor nanoparticle probes containing heavy 
metals have tremendous potential for applications in biomedicine, these 
constituent heavy metals (e.g., cadmium) have well known toxic potential. 
Relatively little is known, however, regarding the hazard potential of these and 
other types of nanoparticles. Size appears to be an important parameter, both for 
their photophysical properties and their toxic potential. As the entire field of 
nanotechnology is based on the size-dependent chemico-physical properties of 
these materials, it is not surprising that relative size would also be an important 
determinant of biological/toxicological effect. Oberdörster reported that surface 
area and particle size played important roles in the toxicity of inhaled TiO2 
particles, i.e., smaller particles induced lung tumors following inhalation at much 
lower exposures than larger particles of the same chemical composition [27]. 
Morgan and coworkers evaluated the pulmonary toxicity of cadmium gallium 
diselenide, copper indium diselenide and cadmium telluride “microparticles”, i.e., 
particles with 1,700-2,550 nm mean diameter, following intratracheal instillation in 
rats. Of the three, cadmium telluride elicited more extensive pulmonary damage 
(expressed as increased lung weight, decreased macrophages, increased lactate 
dehydrogenase and protein content in bronchoalveolar fluid, terminal bronchiolar 
necrosis with fibrin exudates, and type II cell hyperplasia) [28]. Ballou and 
colleagues demonstrated rapid elimination (half-lives of 12-70 minutes) of CdTe-
ZnS nanoparticles following intravenous administration in mice, with surface 
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coating affecting tissue distribution [29]. Liver and lymph nodes were prominent 
sites of accumulation. Voura and coworkers used dihydroxylipoic acid-capped 
CdSe-ZnS semiconductor nanocrystals to label B16F10 tumor cells and follow 
cell extravasation in vivo after intravenous administration of the cells in mice [30]. 
Derfus and coworkers found that CdSe nanoparticles were cytotoxic under 
certain conditions, and the toxicity correlated with the liberation of free Cd2+ ions 
[31]. Lovric and colleagues reported marked cytotoxicity in PC12 and N9 cells 
exposed to CdTe nanoparticle concentrations as low as 10 µg/ml. Cell death was 
associated with chromatin condensation and membrane alterations and was 
more prominent with smaller sized (green,about 2 nm) than larger (red, about 5 
nm) nanoparticles [32].  
An important feature of the potential biological actions of fullerenes is their 
oxidative potential. A number of reports suggest that the carbonaceous fullerenes 
may act as free-radical “scavengers” [33]. Gharbi et al reported that fullerenes 
(up to 2 g/kg) had no acute or subacute toxicity in rats following intraperitoneal 
injection [34]. Interestingly, pristine C60 dramatically protected the liver from 
subsequent exposure to the prototype hepatotoxicant and free radical generator, 
carbon tetrachloride. Fullerenes could be detected in liver using transmission 
electron microscopy. Normal serum marker enzyme (ALT) levels in animals 
pretreated with C60 before carbon tetrachloride suggested a lack of hepatotoxicity 
[34]. A water soluble, polyalkylsufonated C60 preparation elicited essentially no 
evidence of toxicity or histopathology following acute or repeated oral dosing, 
whereas following intraperitoneal (500-600 mg/kg) or intravenous (100 mg/kg) 
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exposure renal toxicity appeared to be the major effect, and the kidneys 
appeared to be the major route of elimination [35]. Yamawaki and Iwai reported 
that endothelial cell cytotoxicity was evident following exposure to hydroxyl 
fullerenes (100 µg/ml for 24 hours): cell death appeared to be mediated through 
a ubiquitin-autophagy activation pathway [36]. Nelson and coworkers reported no 
acute or subchronic dermal toxicity of fullerenes in mice [37]. In contrast o these 
studies,on fullerenes some reports suggest that fullerene aggregates (nC60) may 
induce oxidative stress. Sayes et al reported that nC60 generated a large amount 
of reactive oxygen species at low concentrations, leading to lipid peroxidation in 
biological systems [38]. It has been reported that neither nC60 nor hydroxylated 
C60 elicited respiratory toxicity following either acute or subacute in vivo dosing 
(intratracheal instillation), based on bronchoalveolar lavage (BAL) fluid 
biomarkers, oxidative stress endpoints, airway parenchymal cell proliferation and 
histopathological evaluations [39]. Oberdörster et al reported lipid peroxidation 
and glutathione depletion in the brain of largemouth bass 48 hours after 
exposure to 0.5 ppm uncoated nC60 [40]. Interestingly, Isakovic and coworkers 
reported that gamma-irradiated nC60 did not generate ROS or elicit cytotoxicity, 
and suggested that previously reported cytotoxicity of nC60 may at least be 
partially due to residual organic solvent (tetrahydrofuran) used in their syntheses 
[41]. The diversity of findings on fullerene and fullerene aggregate toxicity may 
therefore be due to the different preparation methods used, storage time 
between preparation and use, and other factors, in particular relative to the 
organic solvent(s) used and itsremoval from or retention in the final product.  
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The amount of information available on the toxicity of different 
nanomaterials is limited. Due to different characteristics such as size, shape, 
surface coating, chemical substituents, physical properties, etc., evaluation of the 
toxicity of different nanomaterials requires a case-by-case approach and strict 
adherence to careful charaterization of the materials under study [4, 42].  In 
addition, evaluation of  the adverse effects of nanomaterials should consider the 
potential route of exposure. Inhalation exposure may be more appropriate with 
materials that would likely be air contaminants,  while dermal exposure might be 
the best model when materials are contained in products such as sunblock 
creams. Nanoparticles contained in food or drinking water may be absorbed or 
cross into the gut lymphatics and redistribute to other organs, and oral absorption 
could therefore be a concern [43-45]. Some nanomaterials including nanotubes, 
fullerenes, and quantum dots may be designed to be intentionally introduced into 
the body for diagnostic or therapeutic purposes [34, 46, 47]. In such cases, the 
intravenous exposure route may be appropriate. Surface or other modifications of 
nanomaterials may influence their relative ability to enter cells and tissues/organs 
[40, 48]. Processes of absorption, distribution, metabolism, and excretion of 
nanoparticles may be different based on their surface characteristics. At the 
cellular and molecular level, the interaction between nanomaterials and biological 
target molecules is still unclear. Knowledge of the mechanism of cytotoxicity of 




Mechanisms of Nanotoxicity 
With the widearray of possible constituents making up nanomaterials, 
there are numerous mechanisms that could potentially contribute to their toxicity. 
Oxidative stress has been suggested as a basic mechanism of toxicity that could 
participate in the adverse effects of many types of engineered nanomaterials. 
Oxidative stress is broadly defined as an imbalance between reactive oxygen 
species generated and antioxidant capacity, leading to tissue damage [49]. 
Under physiological conditions, reactive oxygen species (ROS) are generated at 
relatively low rates such that cellular antioxidant systems can counteract their 
reactivity and prevent cellular damage. Oxidative stress leads to a reduction in 
the amount of reduced glutathione (GSH, a major reducing agent in most cell 
types), with a concurrent increase in oxidized glutathione (GSSG). Free radicals 
and peroxides generated under these conditions can damage many cellular 
macromolecules including proteins, lipids, and nucleic acids. Oxidative stress is 
thought to play an important role in various disease processes including 
cardiovascular disease, neurodegenative disease, lung disease, diabetes, cancer 
and others [50-54]. On the other hand, reactive oxygen species can be 
beneficial, e.g., in immune functions in the destruction  of pathogens [55]. 
An important source for reactive oxygen species is the mitochondria, 
produced during the process of oxidative metabolism. In addition, NADPH 
oxidases and cytochromes P450 are capable of generating superoxide. The 
enzymes superoxide dismutase (SOD), catalase and glutathione peroxidase are 
widely known to participate in antioxidant processes. Enriching the antioxidant 
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capacity has therapeutic benefits, e.g., Vitamine E supplementation has been 
used to treat Alzheimer’s disease [56, 57], and radical scavenging drugs have 
been utilized in the treatment of stroke [58].  
A number of studies have evaluated the possible role of oxidative stress in 
lung damage elicited by inhaled particles [4, 59, 60]. Occupational exposure to 
mineral dusts, quartz particles, and asbestos fibers has been shown to elicit 
oxidative damage, inflammation and cytotoxicity. Intratracheal instillation of TiO2 
nanoparticles in rats led to an enhanced inflammatory response compared to that 
elicited by larger size (micro) particles with the same composition and mass [60]. 
Single walled carbon nanotubes induced transient lung inflammation and 
granulomas after intratracheal instillation in rats, possibly through generation of 
reactive oxygen species [25]. The specific properties of engineered 
nanoparticles, their composition and presence of impurities, and environmental 
factors (e.g., light) may modulate the surface of such particles, making them 
more reactive with biological systems. Endpoints of oxidative stress may 
therefore be useful for predicting the relative toxicity of different nanoparticles.  
Cell death elicited by oxidative stress could be mediated either by 
apoptosis or necrosis [61, 62]. Both modes of cell death have distinct 
morphological and biochemical markers. The cell undergoing apoptosis shows 
nuclear condensation, membrane shrinkage and chromatin fragmentation, while 
integrity of the plasma membrane and cellular organelles is maintainted until very 
late in the cytotoxic process. In contrast, necrotic cells show membrane and 
nuclear swelling and membrane damage in relatively early stages, while 
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organelle damage occurs only later. Caspase activation is often a prominent, 
early step in the induction of apoptosis. Proximal caspases cleave and thereby 
activate downstream caspases, and thereby amplify the “death” signal. Apoptosis 
is involved in the toxicity of numerous xenobiotics (e.g., heavy metals, radiation), 
genotoxic drugs and a number of biological ligands such as Fas-L and tumor 
necrosis factor (TNF) [63-66]. Most of these factors can induce apoptosis and/or 
necrosis in a time- and dose-dependent manner [67-69]. 
In the preparation of nanomaterials (e.g., CdTe, carbon nanotubes), metal 
residues are often present, and metal reactivity may change (e.g., because of the 
release of free metal from nanomaterial degradation) between the time of 
nanomaterial synthesis and their use. The intracellular protein metallothionein 
(MT) is known to bind to many heavy metals with high affinity and capacity [67]. 
Metallothioneins are a family of low molecular weight (6-7 kDa), cysteine-rich 
proteins which could be important in binding to heavy metals possibly released 
by metal-containing nanomaterials. Although the physiological function(s) of MTs 
is unclear, heavy metal detoxification and protection against oxidative stress are 
generally agreed to be important activities. MTs participate in the uptake, 
transport, and regulation of zinc in biological systems through binding with the 
thiol group of the cysteine residues. Therefore, by binding and releasing zinc, 
MTs regulate the levels of this essential metal throughout the body. On the other 
hand, cysteine residues from MTs can capture oxidant radicals (e.g., superoxide 
and hydroxyl radicals) [70]. In this reaction, cysteine is oxidized to cystine and 
zinc is released, which can then activate the synthesis of more MTs [71]. Metal-
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containing nanoparticles may therefore activate the synthesis of MT expression 
and this could be important in the regulation of oxidative stress. 
As stated before, relatively little is known about the toxicity of 
nanomaterials. A number of studies suggest that the toxicity of nanoparticles can 
be based on multiple factors related to their different physico-chemical properties 
and extrinsic/environmental conditions [2]. However, the present toxicity data is 
still limited to elucidate the relative hazards and toxic mechanism(s) of diverse 
nanomaterials, including their potential subcellular localization and tissue 
distribution following systemic administration. Due to their relatively larger 
surface area , nanoparticles may be more bioactive than larger, “fine” particles 
made of the same constituents. As noted above, some toxic components (e.g., 
heavy metals) may be released from nanoparticles during synthesis, during 
storage or within biological or environmental systems [31]. In addition, 
nanoparticles may aggregate in biological systems to influence uptake, cellular 
activity, and elimination. On the other hand, nanoparticles may bind to the cell 
surface because of the interaction with cell surface proteins or lipids. One 
possibility is that smaller sized particles may enter cell nuclei and affect gene 
transcription whereas larger particles may fail to enter cells or be restricted to 
distribution only within the cytosol. Differential subcelluar localization of 
nanoparticles could therefore contribute to differential mechanisms of toxicity. 
Nanoparticles may distribute into tissues throughout the body, complex with 
plasma proteins, be retained, or be effectively excreted. All these processes will 
ultimately contribute to the toxic potential of the particular nanomaterial.  
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          The selective use of nanotoxicity, e.g., for targeting cancer cells, has 
numerous applications in medicine. Ovarian cancer is the fifth leading cause of 
cancer deaths in US women. The American Cancer Society estimated over 
22,000 new cases of ovarian cancer with over 15,000 deaths in 2007 [72]. 
Conventional therapy involves surgery followed by chemotherapy or radiation 
therapy to eliminate residual malignant cells. Although surgical techniques and 
chemotherapy have markedly improved in recent years, postsurgical pain and 
complications, non-specific targeting and adverse effects of chemotherapy and 
radiotherapy remain problematic [73]. Development of safer alternatives and 
more selective treatment approaches are needed [74-76]. One of the most 
promising approaches is selective photodynamic therapy (PDT) mediated by 
reactive oxygen species. Photodynamic therapy combines three relatively safe 
elements (photosensitizer, light and oxygen) to produce the ultimate toxicant 
reactive oxygen species, i.e., singlet oxygen (1O2). Essentially, light is used to 
activate a photosensitizer which transfers energy to molecular oxygen, which in 
turn generates singlet oxygen to elicit cytotoxicity. Ideally, the photosensitizer 
would be selectively targeted and accumulate in the cancer cells , thereby 
eliciting selective damage to those cells only. Moreover, PDT can be used in 
combination with chemotherapy, radiotherapy and/or surgery [77]. The first 
generation photosensitizers were hematoporphyrin derivatives, e.g., Photofrin®, 
but considerable side effects were noted with their use. For example, the 
“capillary-leak syndrome” with substantial fluid loss was found in some patients 
after de-bulking surgery and photodynamic therapy [78]. Second generation 
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photosensitizers (e.g., benzoporphyrins, chlorines, naphthalocyanines) have 
some advantages but have lesser selective accumulation in cancerous tissues 
[79].  
The continuing development of nanotechnology has the potential for 
markedly improving a variety of treatments including PDT[80]. A number of 
studies indicate improved drug delivery and targeting via nanomaterial 
conjugation [46]. It was reported that phthalocyanine could be easily taken up by 
HeLa cells after conjugation with gold nanoparticles, enhancing their 
phototoxicity [81]. The photosensitizer meta-tetra (hydroxyphenyl)-chlorin (m-
THPC) embedded in a sol-gel silica matrix generated more reactive oxygen 
species than the same photosensitizer alone [82]. Ideta and coworkers [83]  
reported the utility of a micelle-loaded dendritic form of photosensitizer at 
destroying neovascular lesions contributing to macular degeneration.  
A novel therapeutic strategy referred to as self-lighting photodynamic 
therapy (SLPDT) has been recently designed, using nanoparticle conjugates to 
activate photosensitizers for photodynamic therapy [84]. Nanoparticles are 
conjugated with the photosensitizer and targeted to cancer cells. In the presence 
of irradiation and oxygen, the nanoparticles are activated to emit strong 
luminescence or scintillation, which in turn activates the conjugated 
photosensitizer to locally generate singlet oxygen and destroy the cancer cell 
[84]. For some applications, ZnO nanoparticles may be one of the best 
candidates for this application, e.g., their UV emission matches well with the UV 





Figure 3. Schematic Self-lighting Photodynamic Therapy 
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 excited luminescence has been observed in ZnO nanoparticles [85]. We recently 
reported the synthesis of a number of water-soluble ZnO nanoparticles with 
strong photoluminescence and their conjugation to a porphyrin derivative (meso-
tetra (o-amino phenyl) porphyrin) in aqueous conditions [86].  
In summary, nanomaterials are a diverse group of chemicals with high 
variability in chemical and biological reactivity. The evaluation of toxicity of 
nanomaterials is a requirement for their effective application. Understanding 
basic mechanisms of reactivity and toxicity could aid in the design of safer 
nanomaterial-based products, and potentially in the production of therapeutic 
tools that can harness and focus the biological reactivity of nanomaterials. A 
basic mechanism of toxicity that may be shared among different types of 
nanomaterials is oxidative stress. Based on the above background information, 
we hypothesized that CdTe, fullerenes and zinc oxide-porphyrin conjugates can 
all elicit in vitro and in vivo toxicity via generation of reactive oxygen species and 
subsequent oxidative stress. We investigated the relative cytotoxicity, cytotoxic 
mechanisms and subcelluar distribution of the selected nanoparticles in cultured 
cells. We also evaluated the in vivo effects of CdTe semiconductor nanoparticles 
and their distribution following systemic administration. To test our hypotheses, 
we developed the following specific aims: 
1. Evaluate the toxicity and distribution of CdTe nanoparticles in both cellular 
and mammalian (rat) models 
2. Assess the phototoxicity and subcellular distribution of ZnO-MTAP 
nanoparticle conjugates in human ovarian cancer cells (NIH OVCAR-3) 
 19
3. Investigate the cytotoxicity of fullerene aggregates (i.e., nano C60 or nC60) 
and their cellular distribution in cells 
4. Determine the role of reactive oxygen species/oxidative stress in the 









Chemicals and Reagents 
 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), N-
acetyl-cysteine (NAC), di-ethyl maleate (DEM)), dimethylsulfoxide (DMSO), 
Trypan blue, Dulbecco's Modified Eagle's Medium/Nutrient Mixture F-12 Ham 
(DMEM/Hams’) and RPMI-1640 media were purchased from Sigma Chemical 
Company (St. Louis,  MO). Caspase-Glo 3/7 kit, and Cytotox 96-Non-Radioactive 
Cytotoxicity kit to measure lactate dehydrogenase release (LDH) were purchased 
from Promega Company (Madison, WI). The fluorescent dye Hoechst 33342, 
propidium iodide (PI) and the reactive oxygen species probe CM-H2DCFDA were 
purchased from Invitrogen Corporation (Carlsbad, CA). Fetal bovine serum (FBS) 
was obtained from Hyclone (Logan, UT). The plastic wares for cell culture were 
obtained from Falcon, Becton Dickinson Company (San Jose, CA).  
Cadmium telluride nanoparticles (CdTe) and zinc oxide nanoparticle 
conjugates (ZnO-MTAP) were synthesized at ICx Technologies (Stillwater, OK). 
These nanomaterials were stored 4oC in the dark. Fullerene aggregates (nC60) 
were provided by Dr. Kevin Ausman in the Department of Chemistry at 
Oklahoma State University (Stillwater, OK) and stored at room 
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temperature under dark conditions.  Considering that synthesis methods can 
potentially affect the chemical properties of the nanomaterials, the synthesis 
methods are briefly described below. 
CdTe nanoparticles were prepared by the reaction of cadmium perchlorate 
hydrate [Cd(ClO4)2*H2O] and hydrogen telluride (H2Te) under vigorous stirring. 
The Cd2+ containing solution was prepared as follows: 0.7311 g of 
Cd(ClO4)2*H2O was dissolved in 125 mL of water. Thioglycolic acid (TGA, 0.396 
ml) was added to the solution and the pH was adjusted to ~11 by the addition of 
0.1M NaOH. The solution was then purged with nitrogen for at least 30 minutes. 
H2Te gas was generated by the chemical reaction of excess aluminum telluride 
with 0.5 M sulfuric acid in an inert atmosphere (N2) and was combined with the 
above solution. After the completion of the reaction, a yellowish solution of CdTe 
nanocrystal nuclei was obtained. This solution was then refluxed at 100oC to 
promote crystal growth. Particle size was controlled by reaction time and 
evaluated by transmission electron microscopy. The nanoparticles of different 
sizes were extracted at different reaction times and stored at 4oC in the dark. 
Using a similar procedure, CdTe nanoparticles were also synthesized in air 
instead of N2 as described before [87]. Both samples showed similar 
photoluminescence efficiency.  
For ZnO synthesis, 2.5×10-4 mol of ZnAc2.2H2O and 50 ml of diethylene 
glycol were mixed in a 100 ml three-neck flask, and heated under stirring for 10 
min., resulting in 5×10-3 mol/L of ZnO fluorescent nanoparticles.  Ten ml 5×10-3 
mol/L of such prepared ZnO diethlene glycol solution and 0.1 ml 0.5 M L-cysteine 
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in water were then mixed and heated at 60°C for 48 hr to form ZnO-L-cysteine 
(ZnO-LC). The pH of the obtained ZnO-LC was adjusted to 7.0. The 
nanoparticles were purified with Econo-Pac 10DG desalting column (Bio-Rad) 
with a molecular cut-off of 6 kD. ZnO nanoparticles were conjugated to porphyrin 
by adding 9.58 mg of 1-ethyl-3-dimethylaminopropyl (EDC) to 10.85 mg of N-
hydroxysulfosuccinimide (sulfo-NHS) and mixing into 10 ml 5×10-3 mol/L of ZnO-
L-cysteine solution. This was allowed to react for 15 min at room temperature. 
Then 8.4 mg of MTAP [meso-tetra (o-amino phenyl) porphyrin] was added to and 
allowed to react for at least 2 hr. The pH of the obtained ZnO conjugates was 
adjusted to 7.0 and purified on the desalting column as above.  
Animals 
All procedures involving animals were in accordance with protocols 
outlined in the NIH/NRC Guide for the Care and Use of Laboratory Animals and 
approved by the Institutional Animal Care and Use Committee at Oklahoma State 
University. Male, Sprague-Dawley rats (30 days of age) were used throughout to 
evaluate potential in vivo toxicity of the CdTe (6 nm) nanoparticles. The rats were 
purchased from Harlan Sprague-Dawley (Indianapolis, IN) and housed in steel 
mesh cages with a 12h:12h light:dark illumination cycle and free access to food 
and water. Female BALB/c nude mice (5 weeks of age) from Charles River 
Laboratory were used in ovarian tumor development studies. The mice were 
housed in a micro-isolator cage and given standard autoclaved food pellets and 
water. The animals were allowed to acclimimate for 1 week after arrival.  
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Acute Toxicity and Tissue Distribution Studies 
Animal Treatment 
In the acute toxicity study, rats were divided into 2 experimental groups 
(n=8 per treatment group): control rats received vehicle (PBS, 1 ml/kg via tail 
vein) while treated rats received CdTe red nanoparticles (2 mM, 1 ml/kg).  
In the tissue distribution study, rats were divided into 4 groups (n=6 per 
treatment group): control rats received 1 ml PBS while, the treated groups 
received CdTe red nanoparticles: 5 mM CdTe red nanoparticles at 1 ml/kg, 2 
ml/kg, or 5 ml/kg.  
Tail Vein Injection Procedure 
The treated rat was restrained within a polypropylene device that allowed 
access to the tail vein.  The tail was warmed using a lamp for about 30 seconds 
and then wiped with gauze containing 70% alcohol. The lateral tail vein was 
identified on one side and a tuberculin syringe with a 27-gauge needle was used 
to inject solution into the vein. Fluid could be seen entering the vein during the 
injection. After the needle was removed, a gauze was used to impair bleeding 
before the animal was returned to its home cage. 
Functional and Behavioral Measurements  
           Animals were observed at 0, 0.5, 1, 2, and 4 hours and just before 
sacrifice at 24 hours after dosing. Involuntary movements and SLUD signs 
(acronym for signs of autonomic nervous system disruption including salivation, 
lacrimation, urination, and defection) were evaluated by the method of Moser and 
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 2 (normal quivering of vibrissae, head and limbs); 3 (mild, fine tremor typically 
seen in the forelimbs and head); 4 (whole body tremor). Autonomic dysfunction 
was scored as 1 (normal, no excessive secretion); 2 (slight, 1 SLUD sign or very 
mild multiple signs); 3 (moderate, multiple, overt SLUD signs); and 4 (severe, 
multiple, extensive SLUD signs).  
Locomotor Activity Measurement 
Motor activity was measured for two hours a) on the day before dosing, b) 
immediately following dosing, and then c) 24 hours after dosing. Ambulation and 
rearing were measured using a 16 home-cage-based Photobeam Interruption 
System and the Photobeam Activity System Control Software for Windows NT4 
(PAS, San Diego Instruments, San Diego, CA). Each rat was treated and placed 
into a clean polycarbonate cage (with fresh bedding approximately 2 cm deep) 
just prior to beginning motor activity measurements. Motor activity was measured 
for the subsequent two hours (1000-1200 hrs) and data are reported as counts/2 
hour observation period. 
Clinical Chemistry 
The rats were transferred to metabolic cages (Mini-mitter, #650-0100-00) 
through the remainder of the light cycle for collection of urine and subsequent 
estimation of urine volume, appearance, color, pH, protein concentration, ions, 
glucose, and ketones.  Rats were sacrificed after motor activity measurements 
on the day after dosing. Blood (about 1 ml) was collected via heparinized 
syringes and centrifuged at 10,000 rpm (1 minute) in a microcentrifuge. Plasma 
was analyzed for blood urine nitrogen (BUN), creatinine, alanine 
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aminotransferase (ALT), total protein, albumin, globulin, alkaline phosphatase, 
and total bilirubin.  
Histopathology 
After collecting blood, rats were euthanized and necropsied. A complete 
gross and histological necropsy evaluation was performed on all rats. Brain, liver, 
kidney, lung, heart, and spleen were trimmed and fixed in 10% buffered neutral 
formalin for routine histopathological processing. Slides were evaluated by a 
board certified veterinary pathologist who was “blinded” to treatment.  
Cell Cultures 
Both human hepatoma HepG2 cells and human ovarian carcinoma NIH: 
OVCAR-3 cells were obtained from the American Type Culture Collection 
(Manassas, VA). The HepG2 cell line is a common cell culture model for studying 
xenobiotic-induced hepatotoxicity. The NIH: OVCAR-3 cell line can develop into 
a solid tumor in nude mice and is considered an ideal model system to study 
drug resistance/therapy of human ovarian cancer. HepG2 cells were maintained 
at 37oC (5% CO2, 95% air) in DMEM/Ham’scontaining 10% fetal bovine serum 
and 1.5 g/L sodium bicarbonate.  OVCAR-3 cells were grown at 37oC (5% CO2, 
95% air) in T-75 culture flasks containing RPMI culture medium supplemented 
with 1 mM sodium pyruvate, 0.01 mg/ml bovine insulin and 10% fetal bovine 
serum. Fresh medium was replaced every other day. Confluent cells were 
harvested with 0.25% trypsin-EDTA solution. Before treatment with 




Trypan Blue Exclusion Assay 
In some assays, cell viability was estimated by the trypan blue exclusion 
assay. Viable cells exclude the dye, thus trypan blue uptake therefore suggests 
loss of viability. Following varying conditions, culture medium (500 µl/well) was 
aspirated and cells were sedimented by centrifugation (4,500 rpm for 5 min). The 
remaining cells on the plate were treated with 0.25% Trypsin-EDTA, triturated, 
and combined with original cells. Cells were then loaded on a hematocytometer 
slide with trypan blue at the ratio 1:1 (v/v), and the number of viable cells 
(unstained) and dead cells (stained) were counted in quadruplicate samples 
under light microscope. Cell viability was calculated as 100 × (unstained 
cells)/(stained +unstained cells). 
LDH Assay 
          Lactate dehydrogenase (LDH) release was also used in some assays to 
evaluate viability. This colorimetric assay quantitatively measures LDH release 
upon cell plasma membrane damage. LDH is measured with a coupled 
enzymatic assay that results in the conversion of a tetrazolium salt (INT) into a 
red formazan product. The amount of color formed is proportional to the number 
of lysed cells. Following incubation of cells with nanoparticles, 50 ul of 
supernatant was removed to another plate followed by addition of 50 ul of 
substrate mix. The plate was covered with foil to protect it from light and 
incubated for 30 minutes at room temperature. Fifty ul of a stop solution was then 
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added to each well. Absorbance was measured at 490 nm using a microplate 
reader (Wallace 1420 Victor 2, Perkin Elmer Inc).  
MTT Assay 
 The colorimetric MTT ((3-(4, 5-dimethylthiazol-2-yl) 2, 5-diphenyl 
tetrazolium bromide) test assesses cell metabolic activity based on the ability of 
the mitochondrial succinate-tetrazolium reductase system to convert the yellow 
dye (MTT) to a blue-colored formazan. Metabolic activity is proportional to the 
colored product formed [89]. Briefly, following incubation of cells with 
nanoparticles, the media was aspirated and replaced with 90 ul of serum-free 
media.  Ten µl of an MTT stock solution (5 mg/ml) was added to each well 
followed by incubation for 4 hours at 37oC. The supernatant was then removed 
and cells were lysed with 100 µl DMSO. Absorbance was recorded at 550 nm 
using a microplate reader. 
Caspase 3/7 Assay 
          Caspase 3/7 activity can be used to detect induction of apoptosis. Cells 
were exposed to nanoparticles for varying times. The luminogenic caspase 3/7 
substrate containing the tetrapeptide sequence DEVD was used for caspase 3/7 
cleavage and generation of a luminescent signal following a standard protocol 
(Promega, Madison, WI). Briefly, 100 µl of Caspase-Glo3/7 reagent were added 
to each well followed by incubation at room temperature for 1 hour. The 
luminescence of each sample was measured using a microplate reader. 
 Measurement of Reactive Oxygen Species  
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Total reactive oxygen species (ROS) were measured using the specific 
molecular probe CM-H2DCFDA (Invitrogen, Carlsbad, CA). This reagent is a cell-
permeant indicator for reactive oxygen species that is non-fluorescent until 
acetate groups are cleaved by endogenous esterases and subsequent 
oxidization by ROS. The fluorescence intensity is proportional to the 
concentration of ROS [90]. Phosphate buffered saline containing 1% fetal bovine 
serum was incubated with CM-H2DCFDA (10 µM) in 96 well plates for 30 min at 
37oC. A range of concentrations of nanoparticle or nanoparticle conjugates was 
then added, with or without UVA irradiation (0, 1.5, 3, 6 or 9 kJ/m2). The intensity 
of fluorescence was determined using a microplate reader with 
excitation/emission at 485 nm/530 nm. 
Intracellular ROS levels were monitored using CM-H2DCFDA. After 
treatment, the medium was removed and replaced with serum free medium. After 
30 min of incubation with 10 µM CM-H2DCFDA, the cells were rinsed three times 
with PBS. Intracellular fluorescence was measured through scanning the whole 
well using excitation and emission wavelengths of 485 and 530 nm with a 
microplate reader. The values were expressed as percent of intensity in control 
wells.  
DNA Fragmentation Assay 
            DNA fragmentation is a hallmark of apoptosis. HepG2 cells were collected 
by centrifugation at 1,000 rpm/min for 5 minutes and the supernatant was 
discarded. The pellet was washed with PBS and then lysed in 500 µl lysis buffer 
(0.5% Triton x-100, 20 mM EDTA and 5 mM Tris pH 8) at 50oC for 45 minutes. 
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The lysate was first extracted with 500 µl of phenol:chloroform:isoamyl alcohol 
(25:24:1) twice, and once with 100% chloroform. Then, 50 µl of 3 M sodium 
acetate were added and nucleic acids were precipitated overnight with 1 volume 
of ethanol. The pellet was then collected by centrifugation at 12,000 x g at 4 oC 
for 10 minutes. The pellet was washed with 70% ethanol, air-dried and dissolved 
in 100 µl of 10 mM Tris, 1 mM EDTA, pH 8 (TE) buffer. RNA was digested with 
RNase (0.5 µg/ml) at 56oC for 2 hours. DNA concentration was quantified with a 
Nanodrop and then analyzed by 1.8% agarose gel electrophoresis in 45 mM Tris-
borate containing 1 mM EDTA. Twenty µg of DNA was loaded into each well and 
separated at 1.5 v/cm for 3 hours. DNA was stained with ethidium  
bromide, visualized under UV light and photographed.  
Western Blotting 
Metallothionein protein level was determined by western blot, using β-actin 
as an internal standard. CdTe nanoparticle treated and untreated HepG2 cells 
were rinsed twice with PBS (pH 7.4). Total proteins were extracted by adding 500 
µl of cold lysis buffer [200 mM Tris–HCl (pH 7.4), 500 mM NaCl, 100 mM EDTA, 
100 mM phenylmethanesulfonyl fluoride; 100 mM DTT, 10 mM Typsin inhibitor 
and 0.3% Tween-20] to the cell pellets for 30 min on ice.  The mixtures were 
centrifuged at 10,000 x g for 30 min at 4°C.  The cytosolic  supernatant proteins 
were measured by the Bradford assay with bovine serum albumin (BSA) as the 
standard. Samples (20 µg of protein) were mixed with 5x sample buffer 
containing 0.3 M Tris–HCl (pH 6.8), 25% 2-mercaptoethanol, 12% sodium 
dodecyl sulfate (SDS), 25 mM EDTA, 20% glycerol and 0.1% bromophenol blue. 
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The mixtures were boiled at 95°C for 5 min, and then  loaded onto and separated 
in 12% SDS–polyacrylamide minigels at a constant current of 20 mA. Following 
electrophoresis, proteins were transferred onto a membrane (PVDF, Millipore) 
with transfer buffer (192 mM glycine, 25 mM Tris–HCl pH 8.9, and 20% 
methanol) for 2 hours at 40 volts. The membrane was then washed with Tris-
buffered saline (10 mM Tris pH 8.0, 150 mM NaCl) containing 0.05% Tween-20 
(TBST) and blocked in TBST containing 5% non-fat dried milk. The membrane 
was further incubated at 4°C for 2 hours with  specific antibodies MT (1:2000) and 
β-actin (1:5000). After hybridization with primary antibodies, the membrane was 
washed with TBST three times, incubated with horseradish peroxidase-labeled 
secondary antibody for 60 min at room temperature, and then washed with TBST 
(3x). Detection was performed with ECLTM (Enhanced Chemiluminescence) 
western blotting reagents (Amersham Pharmacia Biotech). 
Real time RT-PCR 
        The expression of metallothionein RNA was quantified by real time reverse          
transcription–polymerase chain reaction (Real-time RT-PCR) analysis. Beta-actin  
mRNA was used as an internal standard control.  HepG2 cells were plated into 
100 mm tissue culture dishes and allowed to attach for 24 hours. Various 
concentrations of CdTe nanoparticles were added to the cells for 24 hours. RNA 
was extracted with TRIzol RNA isolation kit (Invitrogen) according to 
manufacturer’s instructions. Total RNA (1 µg) was treated with 1 µl DNase I 
(Invitrogen) at 370C for 30 minutes to remove contaminating genomic DNA. The 
sense and antisense sequence primers used were: MT II: 5´-CCG ACT CTA 
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GCC GCC TCT T-3´, 5´-GTG GAA GTC GCG TTC TTT ACA- 3´; β-actin: 5’-
AGAAAATCTGGCACCACACC-3’; 5’-GGGGTGTTGAAGGTCTCAAA-3’. For 
each sample, 1 µg of RNA was reverse-transcribed. cDNA was synthesized 
using 200 ng random primers (Invitrogen), 200U superscript II reverse 
transcriptase and 0.25 mM dNTP mix. Reaction mixtures were then treated with 
E. coli RNase H at 370C for 20 minutes to remove RNA.  The 20-µl real-time 
PCR amplification mixture contained 2 µl of template cDNA, 1 µl of primer (10 
uM) mix, and 10 µl of 2x SYBR master mix (Applied Biosystems). Reactions were 
conducted at 50°C for 2 min and 95°C for 10 min, foll owed by 40 cycles at 95°C 
for 15 s and 60°C for 1 min. Relative gene expression  was calculated as 2–CT 
(threshold cycle) values. Real-time PCR was performed on an ABI PRISM 7500 
(Applied Biosystems).  
Microscopy 
Tissue Distribution using TEM 
In the tissue distribution studies, samples of livers and brains were 
collected 24 hours after treatment. Tissues (approximately 1 gram) were digested 
and Cd levels measured using atomic absorption spectrometry. The limit of 
detection was 0.01ppm.  
Liver and brain were collected and cut into 1 mm cubes and immediately 
immersion fixed in buffered (pH 7.0-7.2) 2% glutaraldehyde. The samples were 
dehydrated in ethanol and embedded in 100% embedding medium. Thick and 
thin sections specimen were cute using an ultramicrotome (Sorvall MT-6000). 
Tissue samples were evaluated using transmission electron microscopy (JEOL 
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JEM-2100) either without prior staining or following staining with Au/Pb, and 
analyzed bywith X-ray scanning. 
Subcellular Distribution using Confocal Microscopy 
HepG2 cells or OVCAR-3 cells were exposed to CdTe nanoparticles (10 
µM) or ZnO-MTAP nanoparticle conjugates (10 µM) for 1hour or 24 hours and 
examined using confocal microscopy. Cover slips with attached cells were 
washed 5 times to remove non-incorporated particles and sealed onto glass 
slides. Images were captured with a Leica TCS Sp2 microscope. The excitation 
wavelength was 480 nm and emission wavelengths were 640 nm, 570 nm and 
530 nm for CdTe-red, -yellow or -green nanoparticles, respectively. With ZnO-
MTAP conjugates, the excitation wavelength was 360 nm and the emission 
wavelength was 630 nm. CdTe nanoparticle localization was analyzed using 
Scion image software (Frederick, Md., USA).  
Hoechst /PI Staining 
Hoechst 33342 and propidium iodide (both from Invitrogen) were used to 
distinguish apoptotic and necrotic cells, based on nuclear morphology. Hoechst 
33342 is a cell-permeant dye, whereas propidium iodide (PI) does not penetrate 
the plasma membrane of viable cells. Condensation of the nucleus stained with 
Hoechst 33342 is considered an indicator of apoptosis. In contrast, PI uptake 
indicates necrotic cells or cells in late-stage apoptosis, i.e., following loss of 
membrane integrity. OVCAR-3 cells were seeded into 24 well plates (1 x 105 
cells/ml, 500 µl/well) and exposed to both ZnO nanoparticle conjugates (10 µM) 
and UVA (9 kJ/m2). Thirty minutes before the end of the incubation period (3, 12 
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or 24 hours), Hoechst 33342 stain (5 µM, 30 min) or PI (2 µM, 15 min) was 
added. Cells were washed three times with phosphate buffered saline. Nuclear 
morphology was evaluated using a Nikon Eclipse TE 2000-u fluorescence 
microscope using UV filter for Hoechst 33342 staining and a G filter for PI 
staining.  
Photodynamic Therapy of Nanoparticle Conjugates 
Ultraviolet Irradiation Treatment 
Irradiation of cells was conducted in a laminar flow hood. To determine the 
uniform area of UVA light irradiation, a Newport power meter (Model 1815-C) 
with an OD3 attenuator (883-UV, S/N 3995) was calibrated to 365 nm with low 
power. To study the effect of UVA on ovarian cancer cells, 96-well plates 
containing 1 x 104 cells/well were placed under the UVA lamp (Fisher Biotech 
FBUVLS-80) for 30, 60, 90 or 120 min (0.50 mW/cm2), corresponding to an 
irradiation dose of 9, 18, 27 or 36 kJ/m2. For dark conditions, plates were 
completely covered with aluminum foil to block any light entry into the plates and 
kept under the hood for the same time/conditions as cells being exposed to UVA. 
All plates were placed back into the cell culture incubator. Twenty hours after 
terminating irradiation, metabolic function was evaluated using the MTT assay.  
In Vitro Photodynamic Therapy 
OVACAR-3 cells (1x 105 cells/ml, 100 µl/well) were treated with ZnO-
MTAP conjugates (0, 1 or 10 µM) for four hours and then washed three times 
with phosphate buffered saline. Cells were then exposed to either dark or UVA (9 
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kJ/m2) as described above. Twenty hours later, cell viability was measured using 
the MTT assay.  
Development of Ovarian Tumor Model in vivo 
A long term goal of this project was to evaluate phototoxicity of the 
nanoparticle conjugates in vivo. We therefore attempted to develop a solid tumor 
model of the NIH:OVCAR-3 cells. Female BALB/c nude mice (5 weeks of age) 
were obtained from Charles River Laboratories (Wilmington, MA). The animals 
were housed in a micro-isolator cage and given standard autoclaved pellets and 
water. The mice were allowed to acclimate for 1 week and then treated with 
OVCAR-3 cells or vehicle. OVCAR-3 cells were cultured in T-75 culture flasks at 
37oC in a humidified atmosphere with RPMI 1640 culture medium supplemented 
with 10% fetal bovine serum (FBS). Cells at the seventh passage were harvested 
with 0.25% trypsin for 3 min and then resuspended in culture medium without 
FBS. After 3 washes with phosphate buffered saline (centrifugation at 1,000 rpm 
for 5 min), cells were stained with Trypan blue and viability counted with a 
hemocytometer. 
           To optimize the dose of cells for tumor growth, 8 mice were randomly 
divided into four groups and inoculated with 0, 1 x 107 (low dose), 1.8 x 107 
(medium dose) or 2.4 x107 (high dose) cells in 300 ul of PBS. Control mice were 
injected (i.p.) with 300 µl of PBS.  Mice were observed every other day for 10 
weeks for changes in body weight and general cage-side behavior/appearance. 
Tumor size was measured using a slide caliper and calculated using the 
standard formula: volume= length x (width) 2/2.  
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At the end of the 10 week observation period, mice were euthanized with 
carbon dioxide. Blood was collected through cardiac puncture into a heparinized 
microtube. The tumor mass was demarcated and weighed. Organs and tissues, 
including the tumor, were removed and fixed in 10% formalin, and 
histopathological examination was conducted to evaluate tumor morphology. 
Statistical Analysis 
In MTT assays, LDH assays, caspase assays and real-time PCR 
analyses, data were reported as mean ± standard error (SE) based on at least 
triplicate observations from three independent experiments. Statistical 
significance was determined by one-way analysis of variance (ANOVA) followed 
by Dunnett’s multiple comparison test. Graded responses were evaluated using 
MANOVA. Phototoxicity and oxidative stress data were analyzed with student’s t-
test. In all cases, p<0.05 was considered statistically significant. All statistical 













Toxicity of CdTe NPs in vitro and in vivo 
 
Cytotoxicity of CdTe Nanoparticles 
We used the trypan blue, LDH and MTT assays to evaluate cell viability in 
HepG2 cells following exposure to CdTe nanoparticles. The time-dependent 
effects of CdTe nanoparticles on cell viability is shown in Figure 4. 
Concentration-dependent effects are shown in Figure 5, Figure 6, and Figure 7. 
Moreover, Figure 7 shows that CdTe-Red (6 nm), CdTe-Yellow (4 nm), and 
CdTe-Green (2 nm) nanoparticles may elicit size dependent cytotoxicity. The IC50 
(concentration causing 50% reduction in cell viability measured by the MTT 
assay) values of the three nanoparticles were 19.1, 4.8, 3.0 uM for CdTe-Red, 
CdTe-Yellow and CdTe-Green particles, respectively. One possibility for 
cytotoxicity in these preparations was that free cadmium may have been in the 
samples as prepared. We therefore purified a sample of CdTe-red using 
methanol extraction, and then compared the cytotoxicity of the sample as 
prepared with purified sample. Figure 8 shows that, although the purified 
nanoparticles still exhibited similar photophysical properties with the “as 
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prepared” sample, their cytotoxicity was markedly reduced. These data suggest 
that the CdTe nanoparticles as prepared may indeed have some free cadmium 
or other contaminant that is cytotoxic.  
One potential problem in the use of any nanomaterial is aggregation. We 
examined the time-dependent aggregation of CdTe-Red nanoparticles using 
microscopy. There was apparent aggregation/agglomeration of the CdTe-Red 
nanoparticles over time (Figure 9). The aggregation of the particles appeared to 
be primarily extracellular, however, as similar aggregates were noted when 
culture medium containing the nanoparticles was incubated in the absence of 
any cells (data not shown).  
Traditionally, water soluble CdTe nanoparticles have been synthesized 
under inert conditions. Figure 10 shows that synthesis in either air or nitrogen 
had little apparent effect on the the cytototoxicity of CdTe-red particles. With the 
smaller CdTe-yellow and CdTe-green nanoparticles, there was a suggestion of 
lesser cytotoxicity with nanoparticles synthesized in nitrogen relative to those 
synthesized in air (Figure 11, 12). It must be stressed, however, that there were 
statistical differences in cytotoxic potential between CdTe nanoparticles prepared 
in either air or nitrogen.  
Evaluation of Mode of Cytotoxicity Induced by CdTe Nanoparticles 
There are two basic types of cell death,  apoptosis and necrosis. To 
determine the cytotoxic mechanism of CdTe nanoparticles in HepG2 cells, we 
used three methods to evaluate apoptosis. Figure 13 shows that nuclear 
condensation, an indicator of apoptosis, was elicited after 24 hours incubation 
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with CdTe-red particles, but not at an earlier timepoint (i.e., 4 hours). Similarly, 
caspase 3/7 activity was induced by CdTe-red particles in a dose- and time-
dependent manner (Figure 14 and 15). In addition, the hallmark of apoptosis, 
DNA fragmentation, appeared after 48 hours exposure to CdTe-Red 
nanoparticles (Figure 16).  
Effect of CdTe Nanoparticles on Metallothionein Expression 
Our previous study showed that free cadmium may at least partially 
contribute to the cytotoxicity of CdTe nanoparticles. It is well known that cadmium 
could induce the expression of metallothionein in HepG2 cells. Therefore, we 
evaluated metallothionein expression in HepG2 cells exposed to CdTe 
nanoparticles. Figure 17 shows metallothionein mRNA level was increased by 
CdTe nanoparticle at lower concentrations (0.2 to 1 µM) but was reduced at 
higher concentrations (20 - 100 µM).  Figure 18 shows that metallothionein 
protein levels were decreased in CdTe treated cells.  
Effect of the Size of CdTe Nanoparticles on Their Subcellular Distribution 
As mentioned before, the size of CdTe nanoparticles can play an 
important role in their optical properties and cytotoxic potential. Size may be also 
critical in cellular transport processes as they interacted with biological 
membranes and channels. Therefore, we evaluated subcellular distribution of 
different sized CdTe nanoparticles.  Figure 19 shows apparent size- and time-
dependent distribution of CdTe nanoparticles in HepG2 cells. After 1 hour 
incubation, CdTe-Red (6 nm) and CdTe-Yellow (4 nm) particles appeared mainly 
bound to the plasma membrane while CdTe-Green (2 nm) appeared to be visible 
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in the cytosol. After 24 hours exposure, however, CdTe-Red (6 nm) and CdTe-
Yellow (4 nm) appeared to be more diffusely located within the cytoplasm while 
CdTe-Green (2 nm) appeared to distribute into the nucleus.  
Acute Toxicity of CdTe-Red Nanoparticles in Rats 
Twenty-four hours after treatment, there was a slight but significant 
reduction in body weight of CdTe-Red treated rats relative to controls (Figure 20). 
Core body temperature twenty-four hours after treatment was unaffected (data 
not shown).  
Rats were graded before treatment and at 0.5, 1, 2, 4 and 24 hours after 
treatment for functional signs of toxicity as described in methods. No overt signs 
of toxicity were observed in either nanoparticle-treated or control groups at any 
timepoint (data not shown). Figures 21 and 22 show motor activity was affected 
by systemic CdTe-Red nanoparticle treatment. Rearing scores were significantly 
reduced in nanoparticle-treated rats compared to vehicle controls from 0-2 hours 
after dosing, and there was a non-significant trend towards reduced ambulation. 
Interestingly, both rearing and ambulation counts were significantly increased 24 
hours following nanoparticle exposure. There were no treatment-related 
differences in any blood-borne clinical endpoints measured (Table 1). Similarly, 
there were no significant effects of nanoparticle treatment on urinary indicators 
including protein, glucose, ketones, bilirubin or blood cells in the urine (Table 2). 
Following routine histopathological analysis, there were no treatment-related 
histopathological changes in any tissues (data not shown). Figure 23 shows a 
 41
microthrombosis of a small venule in lung tissue noted in both control and treated 
rats, and thus not related to treatment. 
Tissue Distribution of CdTe Nanoparticles 
           CdTe nanoparticles appear to distribute within cells in a size-dependent 
manner (Figure 19). Evaluation of the distribution of nanoparticles in vivo will help 
determine whether the particles are effectively distributed and accumulate in 
tissues, or effectively blocked from entry into some tissues and eventually 
eliminated. Figures 24 and 25 show that cadmium accumulated in both brain and 
liver tissue in a dose–dependent manner 24 hours after CdTe nanoparticle 
treatment. Figure 26 and 27 shows liver imaged with TEM. Figure 26A is a 
sample of CdTe nanoparticles alone, while Figure 26B is a section of unstained 
liver following treatment with CdTe-Red in vivo. As noted in this figure,  particles 
of about the same size as CdTe-Red can be seen in the unstained tissue. In 
contrast, no such particles were noted in tissues that had been stained for TEM 
(uranyl acetate and lead,  Figure 27). X-ray scanning analysis in Figure 27 
confirmed both Cd and Te in the particles, possibly an indicator that intact CdTe 
nanoparticles had entered the tissues following systemic administration. 
Cytotoxicity of Fullerene Aggregates (nC60 ) 
Effect of Synthetic Methods and Size on Cytotoxicity of nC60  
It has been reported that the chemical and physical properties of nC60 
aggregates made through either solvent exchange or by extended stirring in 
water may have different properties [91].We therefore compared the cytotoxicity 
of nC60 aggregates synthesized through four different methods, i.e., solvent 
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extraction using tetrahydrofuran (THF), solvent extract using 
toluene/tetrahydrofuran/acetone (TTA), by sonication with toluene extraction 
(SON), or by prolonged stirring in aqueous media alone (AQ). Figure 28 shows 
that synthetic conditions may indeed influence the cytotoxicity of fullerene 
aggregates. Aggregates synthesized by extraction with TTA were more potent at 
reducing cell viability than aggregates prepared by the other three methods. 
Interestingly, when all samples were extensively evaporated to attempt to any 
residual organic solvent, the aggregates prepared by the AQ method now 
showed higher cytotoxicity (Figure 29), Cytotoxicity of the AQ sample was also 
concentration–dependent (Figure 30).  
As noted before, oxidative stress has been hypothesized to contribute to 
the cytotoxicity of a variety of nanomaterials. We therefore evaluated whether 
nC60 could produce ROS. Figure 32 shows that nC60 produced ROS in a time-
dependent manner. The cytotoxic potential of three different sized nC60 (119, 145 
and 152 nm) were studied. Figure 31 shows that, within this size range, there is 
no apparent size-related difference in cytotoxicity. .   
Phototoxicity of ZnO-MTAP NP Conjugates  
Reactive Oxygen Species Generation by Nanoparticle Conjugates 
The principle of self-lighting photodynamic therapy was described in the 
previous chapter. The generation of ROS under irradiation is the key aspect of 
this approach. We thus evaluated if ZnO-MTAP conjugates could generate ROS 
under dark or UVA irradiation conditions. Figure 33 shows ROS production by 
different concentrations of ZnO-MTAP conjugates under dark and light 
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conditions. Essentially, no evidence of ROS generation was noted with ZnO-
MTAP conjugates under dark conditions, while concentration- and irradiation 
dose-dependent effects were noted with UVA irradiation.  
Cellular Localization of ZnO-MTAP Conjugates 
We investigated if the conjugates could be taken up by ovarian cancer 
cells. OVCAR-3 cells were incubated with ZnO-MTAP conjugates (10 µM for 4 
hours), and then evaluated with confocal microscopy. Figure 34 shows that the 
conjugates appeared to be primarily localized within the cytosol at this time.  
In vitro Photodynamic Therapy 
Since the nanoparticle conjugates were taken up into the cells, we 
proposed to see if the drug could be activated under irradiation. Therefore, we 
compared the phototoxicity and dark toxicity of ZnO-MTAP in OVCAR-3 cells. 
Figures 35 and 36 show OVCAR-3 cell viability was affected by increasing 
concentrations of ZnO-MTAP conjugates (24 hour exposure) or increasing 
intensity of UVA irradiation. Using the MTT assay, no effects on cell viability were 
seen with 0.1-10 µM ZnO-MTAP conjugates, whereas cell viability was reduced 
with the highest UVA intensity (36 kJ/m2). Phototoxicity of the ZnO-MTAP 
conjugates was then evaluated using a subtoxic UV exposure. As shown in 
Figure 37, neither UVA (9 kJ/m2) nor ZnO-MTAP nanoparticle conjugates alone 
affected cell viability. When cells were exposed to both conjugates and UVA, 
however, concentration-dependent reduction in viability was noted, with maximal 
(92%) reduction in viability noted with UVA illumination and the higher 
concentration (10 µM) of ZnO-MTAP conjugates.  
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Cell Death Induced by ZnO-MTAP Conjugates and UVA Irradiation 
           Figure 38 shows that caspase 3/7 was activated from 3-6 hr after 
exposure to ZnO-MTAP conjugates and UVA irradiation, but caspases 
decreased at later time-points. Figure 39 shows Hoechst 33342 and propidium 
iodide staining from 3-24 hr after similar exposure conditions. Nuclear 
condensation with Hoechst 33342 staining at 3 hr after treatment suggested an 
early apoptotic response. Uptake of propidium iodide at 12 hours after treatment 
suggested a delayed necrotic response. At the latest timepoint examined (24 hr), 
most of the cells showed propidium iodide uptake indicating widespread 
membrane damage and likely necrosis.  
Table 3 shows the different types of nanoparticle conjugates that were 
evaluated for cytotoxic potency under dark and irradiated conditions, using either 
UVA, X-ray or laser. Of all, only the ZnO-MTAP showed any potential for 
photoactivation.  
Development of Ovarian Tumor in Nude Mice 
As described before, nude mice were injected with vehicle or one of three 
concentrations of NIH OVCAR-3 cells. There were no gross functional changes 
in any mice throughout the 10-week period. Mice that developed tumors moved 
somewhat slower than mice that had no obvious tumor. However, two mice in the 
high dose group (s.c.) showed apparent ascites accumulation at the sixth week 
after inoculation, and exhibited a solid mass on the seventh week. In the eighth 
week after inoculation, another high-dose mouse, one medium dose, and one 
low dose mouse exhibited a tumor on the abdomen near the site of injection. One 
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medium dose mouse (i.p) began to develop ascites during the eighth week post-
inoculation.  
Tumor size was measured using a slide caliper. Solid tumors developed in 
6 of 8 inoculated mice, including 5 in subcutaneous tissue and 1 in the peritoneal 
cavity.  Body weight changes were not dose-related (Figure 40), while the rate of 
tumor growth was dose-related, i.e., the higher dose led to more extensive tumor 
growth (Figure 41-42). The neoplasm developing in subcutaneous tissue was 
attached to the external body wall and did not invade the peritoneal cavity (Figure 
43). However, the neoplasm that developed in the peritoneal cavity showed 
“milky” fluid in the abdomen (Figure 44). Figures 45-47 demonstrate the 
microscopic morphology of subcutaneous and intraperitoneal tumors in H&E 
stained tissue sections. The neoplastic cells in subcutaneous and intraperitoneal 
tissues were evaluated via light microscopy, confirming proliferation of neoplastic 
cells at the different inoculation sites. Peritoneal fluid from the mouse with “milky” 
ascites was cytologically evaluated to confirm the presence of neoplastic cells 
(Figure 48). All mice were alive at 10 weeks  post-inoculation at each of the three 
doses. These results suggest that the solid tumor model can be easily developed 
for any future studies.  
Effect of Pre-exposure of N-acetyl Cysteine or Diethyl Maleate on 
Toxic Potential of CdTe, nC60, and ZnO-MTAP/UVA  
Oxidative stress can be modulated by conditions which either increase or 
decrease antioxidant status. For example, oxidative stress mediated toxicity can 
be reduced by supplementing intracellular antioxidant levels, e.g., by increasing 
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glutathione levels. On the other hand, ROS-mediated cytotoxicity can be 
increased by prior reduction of intracellular antioxidant levels, e.g., by reducing 
glutathione levels by preexposure to diethyl maleate. HepG2 or OVCAR-3 cells 
were pre-treated with the glutathione precursor N-acetyl-cysteine (NAC, 5 mM) to 
evaluate the effects on cytotoxicity of various nanoparticles/ conjugates. In 
parallel studies, cells were pre-treated with the glutathione depletor diethyl 
maleate (DEM, 200 uM). H2O2 was used as a positive control. Metabolic activity 
(MTT assay), intracellular ROS levels and caspase 3/7 activity were measured to 
determine the influence of antioxidant status on cellular response.  
H2O2 can induce oxidative stress [92]. We therefore used H2O2 as a 
positive control in studies evaluating oxidative stress of nanomaterials. Figures 
49 and 50 show that the cytotoxicity of H2O2 was reduced by NAC pre-exposure, 
and increased by DEM pre-exposure. Figures 51 and 52 show that ROS 
generation by H2O2 was partially blocked by pre-exposure to NAC (5 mM, 2 hr), 
and was increased by DEM pre-exposure (200 µM). NAC alone had no effect on 
ROS levels while ROS was increased by pre-exposure to DEM (200 uM). These 
data suggest that ROS elicited by H2O2 can be influenced in a predictable 
manner by modulating antioxidant by these approaches.  
Several studies suggest cadmium can induce oxidative stress [93, 94]. 
Therefore, we used Cd (NO3)2 as positive control in evaluations of the potential 
for CdTe nanoparticles to induce oxidative stress. Figure 53 shows that 
cytotoxicity of both CdTe and Cd (NO3)2 was greatly reduced by NAC (5 mM, 
2hr) pre-exposure. Free cadmium was more potent than CdTe nanoparticles. 
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The differing dose-related effects on metabolic activity induced by CdTe versus 
Cd (NO3)2 suggest that cadmium containing nanoparticles and free cadmium 
may elicit cytotoxicity via different mechanisms. The reduced toxicity in cells 
preexposed to NAC could be be due to: 1) NAC reduced oxidative stress by 
increasing glutathione levels in the cells or 2) NAC directly adsorbed free 
cadmium released from the nanoparticles. Figure 54 shows that the cytotoxicity 
of CdTe and Cd (NO3)2 was partially increased by pre-exposure to DEM (200 
uM, 2 hr). However, no additive effect was noted. Furthermore, Figure 55 shows 
that ROS levels were not increased by exposure to CdTe (100 µM,  30 minutes), 
with or without pre-exposure to NAC. ROS levels increased with pre-exposure to 
DEM (200 uM) and CdTe exposure, but no additive effects were noted. These 
data suggested that oxidative stress may not be a prominent mechanism in 
CdTe-induced toxicity. The apoptosis induced by CdTe nanoparticles noted 
above may therefore be elicited through other molecular pathways. 
As noted before some investigators have reported that nC60-THF 
aggregates can elicit toxicity through lipid peroxidation [38]. We therefore 
evaluated if the toxicity of nC60-AQ was mediated through oxidative stress. Figure 
56 shows that cytotoxicity of nC60-AQ (3,300 ppm) was partially reduced by NAC 
(5 mM, 2 hr), but was unaffected by DEM (200 uM, 2 hr). Figure 57 shows that 
ROS generated by nC60-AQ aggregates was reduced by NAC pre-exposure, yet 
markedly increased by DEM pre-exposure. These data suggest that oxidative 
stress elicited by nC60-AQ aggregates can be affected by modulating antioxidant 
levels in the cells. Figure 58 shows that caspase 3/7 was not activated in HepG2 
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cells after exposure to nC60-AQ. Toxicity may therefore not be mediated through 
caspase 3/7-induced apoptosis.  
Oxidative stress can also be an important mechanism in photodynamic 
therapy [95, 96]. We evaluated if oxidative stress was important in the cytotoxicity 
of ZnO-MTAP conjugates exposed to UVA. Figure 59 shows that ROS generated 
by ZnO-MTAP/UVA were almost completely blocked by pre-exposure to NAC (5 
mM), and increased by DEM pre-exposure (200 µM). The effect of DEM 
appeared additive in nature (i.e., about 50% increase over ZnO-MTAP/UVA 
alone, and about a 50% increase with DEM alone). Thus, these data suggest that 
ROS elicited by ZnO-MTAP/UVA can be affected in a predictable manner by 
modulating antioxidant levels in the cells. Figure 60 shows that the cytotoxicity of 
ZnO-MTAP/UVA was also substantially reduced by NAC pre-exposure, but 
relatively unaffected by DEM pre-exposure. Further studies need to evaluate the 
effects of DEM on lower concentrations of ZnO-MTAP. Figure 61 shows that 
NAC (5 mM) markedly blocked the increase in caspase 3/7 activity elicited by 
ZnO-MTAP/UVA, suggesting that apoptosis was at least partially mediated by 
oxidative mechanisms. However, while both ZnO-MTAP/UVA and DEM alone 
increased caspase 3/7 activity, there was no apparent additive effect (i.e., the 
combination exposure showed the least increase in caspase). 
 49
 












CdTe-Red  0  uM
CdTe-Red  0.8uM
CdTe-Red  20 uM
CdTe-Red  100uM














Figure 5. Effect of CdTe-Red nanoparticles on HepG2 cell viability. HepG2 cells 
were treated at different concentrations of nanoparticles for 1 day, 2days, 4days, 
and 6 days. At the end of the incubation period, cell viability was determined by 
the Trypan Blue Assay. The data were expressed as mean ± standard deviation 
(SD) for triplicate samples from three independent experiments. An asterisk 
indicates a statistically significant difference compared to control (p<0.05). 
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Figure 6. Effect of CdTe-Red nanoparticles on LDH release in HepG2 cells. 
HepG2 cells were treated with different concentrations of nanoparticles for 24 
hours. Cell viability was determined by the LDH release assay. The data were 
expressed as mean ± standard deviation (SD) for triplicate samples from three 
independent experiments. An asterisk indicates a statistically significant 
difference compared to control (p<0.05). 
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Figure 7. Effects of concentration and size of CdTe nanoparticles on HepG2 cell 
viability. HepG2 cells were cultured with different sized (CdTe-Red, CdTe-Yellow 
and CdTe-Green; 6 nm, 4 nm, and 2 nm) nanoparticles for 48 hours. The MTT 
assay was conducted at the end of the treatment period. The OD value of the 
control cells (nanoparticle-free medium) was taken as 1.0 and proportionate 
change in OD as affected by CdTe exposure was determined. The data were 
expressed as mean ± standard error (SE) using quadruplicate observations from 
three independent experiments. 
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Figure 8. Effects of CdTe-Red nanoparticles as prepared and following partial 
purification on HepG2 metabolic activity. HepG2 cells were cultured with different 
concentrations of CdTe-Red nanoparticles for 48 hours. The MTT assay was 
then conducted to evaluate metabolic viability. The OD value of the control cells 
(nanoparticle-free medium) was taken as 1.0 and proportionate change in OD as 
affected by CdTe-Red exposure was determined. The data were expressed as 
mean ± standard error (SE) for quadruplicate observations from three 











Figure 9.   Aggregation of CdTe-Red nanoparticles. HepG2 cells were cultured 
with CdTe-Red nanoparticles for up to 24 hours.  Images were captured using a 
Nikon Eclipse TS100 light microscope and Nikon Coolpix 995 digital camera at 1, 
4, 8 and 24 hour of exposure (magnification 400×). Arrows point to apparent 


































Figure 10. Effect of synthetic conditions (nitrogen or air atmosphere) on 
cytotoxicity of CdTe nanoparticles. HepG2 cells were cultured with a range of 
concentrations of CdTe-Red nanoparticles (6 nm) made in either nitrogen (N2) or 
air. Nanoparticles were added to cells at concentrations of 0,   10-8, 10-7, 10-6 and 
10-5 M for 24 hours prior to evaluating cell viability by the MTT assay. Cell 
viability was evaluated as affected by exposure to CdTe-red nanoparticles 
synthesized in either N2 or air. Values represent mean ± SEM of three different 
experiments with quadruplicates for each concentration of particles.  
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Figure 11. Effect of synthetic conditions (nitrogen or air atmosphere) on 
cytotoxicity of CdTe nanoparticles. HepG2 cells were cultured with a range of 
concentrations of CdTe-yellow nanoparticles (4 nm) made in either nitrogen (N2) 
or air. Nanoparticles were added to cells at concentrations of 0, 10-8, 10-7, 10-6 
and 10-5 M for 24 hours prior to evaluating cell viability by the MTT assay. Cell 
viability was evaluated as affected by exposure to CdTe-yellow nanoparticles 
synthesized in either N2 or air. Values represent mean ± SEM of three different 
































Figure 12. Effect of synthetic conditions (nitrogen or air atmosphere) on 
cytotoxicity of CdTe nanoparticles. HepG2 cells were cultured with a range of 
concentrations of CdTe-green nanoparticles (2 nm) made in either nitrogen (N2) 
or air. Nanoparticles were added to cells at concentrations of 0, 10-8, 10-7, 10-6 
and 10-5 M for 24 hours prior to evaluating cell viability by the MTT assay. Cell 
viability was evaluated as affected by exposure to CdTe-green nanoparticles 
synthesized in either N2 or air. Values represent mean ± SEM of three different 




Figure 13. Effect of CdTe-Red on nuclear morphology of HepG2 cells. HepG2 
cells (1 x 105 cells/ml) were incubated with CdTe-Red nanoparticles for 4 or 24 
hours. At the specified time after incubation, cells were stained using the nuclear 
dye Hoechst 33342 (10 µM, 30 minutes). Nuclear morphology was observed 

































Figure 14.  Activation of caspase 3/7 by CdTe-Red nanoparticles is 
concentration-dependent. HepG2 cells were exposed to the indicated 
concentrations of CdTe-Red nanoparticles for 24 hours. The luminogenic 
caspase 3/7 substrate containing the tetrapeptide sequence DEVD was used for 
detecting activity. Caspase 3/7 activity of control cells was set to 100%. An 
asterick indicates a significant difference compared to control (p <0.05). 
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Figure 15.  Activation of caspase 3/7 by CdTe-Red nanoparticles is time-
dependent. Cells were exposed to CdTe-red nanoparticles (3 µM) for varying 
times (0, 8, 16, 24, 32 hours). The luminogenic caspase 3/7 substrate containing 
the tetrapeptide sequence DEVD was used to detect activity. Caspase 3/7 
activity of control cells was set to 100%.  
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Figure 16.  DNA fragmentation appears at 48 hours incubation with CdTe-Red 
nanoparticles. HepG2 cells (5 X 106) were incubated with 0, 4, 20, or 100 µM 
(lane 2 to 5) of CdTe -red nanoparticle (6 nm) for 48 hours. Lane 1 contains the 
molecular weight marker. Attached and unattached cells were harvested and 
DNA was resuspended in 0.5% triton-X 100 cell lysis buffer for 45 minutes. DNA 
in the supernatant fraction after centrifugation was extracted twice with 
phenol/chloroform/isoamyl (25:24:1, v/v/v) and once with chloroform, followed by 
precipitation with ethanol. RNA in the pellet was digested with RNAase for 2 hour 
at 56oC. Equal amounts of DNA were separated in agarose gel (1.8%) for 3 hour 
at 1.5 V/cm. DNA in the gel was visualized under UV light after staining with 
ethidium bromide (0.5 mg/ml). 
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Figure 17. Real time RT-PCR analysis of metallothionein mRNA in HepG2 cells 
treated with CdTe-Red nanoparticles. HepG2 cells (2 X 105/ml) were exposed to 
one of a range of concentrations of CdTe-Red nanoparticles for 24 hours. 
Cadmium nitrate (0.2 µM) was used as a positive control. Expression of 
metallothionein (MT) mRNA was analyzed by real time RT-PCR. Beta-actin was 
used as an internal control. The ratio of RT-PCR product of MT-I to beta-actin 
was calculated. The data were expressed as mean ± standard error (SE) for 









   
 
Figure 18. Inhibition of metallothionein levels in HepG2 cells by CdTe-red 
nanoparticles. Cells were exposed to CdTe-red nanoparticles for 24 hours. Total 
protein was isolated and concentration was estimated using the Bradford assay.  
Twenty µg of total protein was denatured and separated on a 12% polyacryamide 
gel. After the protein was transferred to the membrane, the membrane was 
further incubated for 2 hours with specific antibodies for MT (1: 2000) and β-actin 
(1:5000). Then the membrane was incubated with horseradish perooxidase-
labelled secondary antibody for 1 hour. Detection was performed with ECLTM  
chemiluminescence western blotting reagents (Amersham Pharmacia Biotech, 
UK). β-actin, the house keeping gene, was used as an internal control. 
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Figure 19. Size- and time- dependent CdTe nanoparticle distribution in HepG2 
cells. Cells were imaged with 400 nm excitation and A) 630 nm B) 570 nm C) 530 
nm emission following 1 hour exposure to A) 6 nm (CdTe-Red), B) 4 nm (CdTe-
Yellow), or C) 2 nm (CdTe-Green)nanoparticles. Imaging was also conducted 



































Figure 20. Body weight changes at 24 hours after systemic injection of CdTe-Red 
nanoparticles (2 mM, 1 ml/kg) or vehicle. Body weight at Day 0 was just prior to 
injection. The data were expressed as mean ± standard error (SE) (n= 
8/treatment group). An asterisk indicates a statistically significant difference 































Figure 21. Effect of systemic administration of CdTe-Red nanoparticles on 
horizontal motor activity (ambulation) in rats.  Ambulation was measured for two 
hours on the day before dosing (Day-1), on the day of treatment (Day 0), and on 
the day after dosing (Day 1). Photobeam interruptions were recorded as 
described in Methods. The data are expressed as mean ± standard error 
(n=8/treatment group). An asterisk indicates a statistically significant difference 
































Figure 22. Effect of systemic administration of CdTe-Red nanoparticles on 
vertical motor activity (rearing) in rats.  Rearing was measured for two hours on 
the day before dosing (Day -1), on the day of treatment (Day 0), and on the day 
after dosing (Day 1). Photobeam interruptions were recorded as described in 
Methods. The data are expressed as mean ± standard error (n= 8/treatment 
group). An asterisk indicates a statistically significant difference compared to 




Figure 23.  Microthrombosis of a small venule in the lung of a treated rat 24 
hours after intravenous injection CdTe nanoparticle. This type of  lesion was also 
seen in control animals and was therefore not treatment related. 
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TABLE 1 Effect of systemic CdTe-Red nanoparticles on plasma chemistry 










Alanine amino transferase  
 
IU/L 70.4 ± 3.3* 91.4 ± 8.9 
Total Bilirubin mg/dL 0.14 ± 0.04 0.13 ± 0.02 
Alkaline phosphatase IU/L 460 ± 11 456 ± 31 
Total Protein g/dL 5.7 ± 0.4 5.5 ± 0.2 
Albumin g/dL 2.74 ± 0.04 2.78 ± 0.06 
Globulin g/dL 2.9 ± 0.4 2.8 ± 0.2 
Albumin/Globulin ratio  0.99 ± 0.08 1.04 ± 0.07 
Cholesterol mg/dL 94.9 ± 1.8 93.1 ± 3.5 
BUN mg/dL 19.6 ± 2.3 17.0 ± 0.9 
Creatinine mg/dL 0.50 ± 0.00 0.50 ± 0.00 
BUN/Creatinine ratio  43.6 ± 5.4 34.0 ± 1.8 
Phosphorus mg/dL 11.7 ± 0.3 11.7 ± 0.2 
Calcium mg/dL 11.2 ± 0.2 10.7 ± 0.2 
Glucose mg/dL 144 ± 2.0 145.6 ± 4.3 
Sodium mEq/L 139.9 ± 0.2 139.6 ± 0.6 
Potassium mEq/L 6.4 ± 0.1 6.7 ± 0.1 
Na/K ratio  22.0 ± 0.6 20.7 ± 0.3 
Chloride mEq/L 96.1 ±1.1 94.9 ±0.9 
CPK IU/L 9436 ± 1441 9097 ± 1703 
1 Male Sprague Dawley rats were treated intravenously (via tail vein) with CdTe-
Red nanoparticles (2 µmol/lkg) or vehicle as described in Methods. Whole 
blood was collected with heparinized needles on the day after dosing and 
plasma collected for measurement of clinical indicators.  
* Values represent mean ± SE of eight rats/group 
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Specific Gravity 1.04 ± 0.01* 1.04 ± 0.01 
pH                  7.6 ± 0.3 7.3 ± 0.3 
 
1 Male Sprague Dawley rats were treated as in Methods and following 2-hour 
motor activity measurements, transferred to metabolic cages for approximately 
6-7 hours for the collection of urine. Glucose, bilirubin, occult blood and protein 
were not detected in any samples.   





















Figure 24. Accumulation of Cd in liver  following systemic treatment with CdTe-
Red nanoparticles.  Livers were collected 24 hours after treatment. Tissues were 
digested and Cd content measured by atomic absorption spectrophotometry. The 
























Figure 25. Accumulation of Cd in brain following systemic treatment with CdTe-
Red nanoparticles. Brains were collected 24 hours after treatment. Tissues were 
digested and the Cd level was measured by atomic absorption 










Figure 26. CdTe nanoparticles in liver after intravenous administration. Livers 
from rats treated with CdTe-Red (25 µmol/kg) were collected and fixed in 2% 
glutaraldehyde 24 hours after treatment. (A) CdTe-Red was deposited on a TEM 
grid and observed via transmission electron microscopy. The black sheres 
appear to be individual CdTe nanoparticles, with diameters around 6 nm (scale 
bar, 20 nm). (B) Livers samples were embedded and processed without staining 
and evaluated by transmission electron microscopy (scale bar, 100 nm). Note 






Figure 27. CdTe nanoparticle detection in liver after systemic administration. 
Liver was collected and fixed in 2% glutaraldehyde 24 hours after administration 
of CdTe-Red  as described above. In this case, tissues were embedded and 
stained with uranyl acetate and lead. The image was captured with JEM 2100 
transmission electron microscope and elemental analysis conducted using X-ray 
scanning (scale bar, 50 nm). Note presence of both Cd and Te.  
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Figure 28.  Effect of synthetic method (THF, TTA, SON, and AQ) on the 
cytotoxicity of nC60 in HepG2 cells. HepG2 cells were cultured with a range of 
concentrations of nC60 made by the THF, TTA, sonication, or AQ method. nC60 
were added to cells at concentrations of 0, 20, 100, 200, 300, 400 ppm for 24 
hours prior to evaluating cell viability by the MTT assay. The data were 
expressed as mean ± standard error (SE) using quadruplicate observations from 





















































Figure 29. Effect of purified nC60 prepared by different methods on cell viability in 
HepG2 cells. nC60 prepared using THF, TTA, Sonication, or AQ methods were 
evaporated extensively using flash evaporation and stored at room temperature 
for one month. HepG2 cells were cultured with these samples at a final 
concentration of 3,300 ppm for 24 hours, prior to evaluating cell viability . The 
data were expressed as mean ± standard error (SE) using quadruplicate 





































Figure 30. Effect of different concentrations of nC60-AQ on HepG2 cell viability. 
nC60–AQ aggregates were added to cells at concentrations of 0, 26, 132, 660, 
and 3300 ppm for 24 hours prior to evaluating cell viability by the MTT assay. 
The data were expressed as mean ± standard error (SE) using quadruplicate 
observations from three independent experiments 
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Figure 31. Effects of concentration and size of nC60-THF aggregates on HepG2 
cell viability. Human HepG2 cells were cultured with a range of concentrations of 
three size of nC60 made using THF method. nC60 aggregates were added to cells 
at concentrations of 0, 26, 132, 660, and 3300 ppm for 24 hours prior to 
evaluating cell viability by the MTT assay. The data were expressed as mean ± 

























   
   
   
   
 
 
Figure 32. Effect of nC60-AQ (3300 ppm) on ROS in HepG2 cells. HepG2 cells 
were cultured with 3,300 ppm of nC60-AQ for 1, 2, 4, or 6 hours. The cells were 
washed with PBS twice and then incubated CM-H2DCFDA (10 µM) in phosphate 
buffered saline for 30 min. Following washing with PBS, the fluorescence 
intensity (indicator of ROS) of the cells was determined using a microplate reader 
with excitation/emission at 485 nm/530 nm. The data were expressed as mean ± 
standard error (SE) using quadruplicate observations.  
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Figure 33. Reactive oxygen species generation by ZnO-MTAP conjugates in the 
presence or absence of UVA light. CM-H2DCFDA (5 µM) was dissolved in PBS 
containing 1% serum and ZnO-MTAP conjugates (0-50 µM) were added 15 
minutes later. The conjugates were then exposed to 0, 1.5, 3, 6 or 9 kJ/m2 UVA. 
The fluorescence intensity (indicate ROS level) of the cells was determined using 








Figure 34. Uptake of ZnO-MTAP nanoparticle conjugates in vitro. NIH: OVCAR-3 
cells were cultured with medium containing ZnO-MTAP conjugates (10 µM) for 4 
hours on a cover slip in 10-cm cell culture plates. Cover slips with attached cells 
were then washed three times to remove free conjugates and sealed on a slide 
with clear nail polish. Images were captured with confocal laser scanning Leica 
TCS Sp2 microscope with excitation at 360 nm and emission at 630 nm. 
Conjugate localization was analyzed using Scion image software (bar = 150 µm). 
Inset image (higher magnification) shows nanoparticle conjugates localized in the 
cytoplasm. 
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Figure 35. Effects of ZnO-MTAP conjugates alone on OVCAR-3 cell viability. 
Cells were seeded into 96-well plates (1x105 cells /ml) and allowed to attach for 
48 hours. The cells were exposed to ZnO-MTAP conjugates (0.1, 1 or 10 µM) 
under dark conditions. Cell viability was evaluated 24 hours later using the MTT 
assay. An asterisk indicates a statistically significant difference compared to 
controls (p < 0.05). 
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Figure 36. Effects of UVA irradiation alone on OVCAR-3 cell viability. Cells were 
seeded into 96-well plates (1x105 cells /ml) and allowed to attach for 48 hours. 
The cells were exposed to UVA at 9, 18, 27 or 36 kJ/m2. Cell viability was 
evaluated 24 hours later using the MTT assay. An asterisk indicates a statistically 
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Figure 37. Effect of co-exposure to ZnO-MTAP conjugates and UVA on OVCAR-
3 cell viability. OVCAR-3 cells were seeded (1 x 105 cells/ml) on 96-well plates 48 
hours prior to treatment with ZnO-MTAP conjugates (1 or 10 µM) under dark 
conditions. After 4 hours, cells were irradiated with UVA at the dose of 0 (dark) or 
9 kJ/m2 and cell viability was evaluated twenty hours later. An asterisk indicates a 
statistically significant difference compared to group II (p < 0.05). A pound or 
dollar sign indicates a statistically significant difference compared to group III or 
group IV, respectively (p < 0.05).  
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Figure 38. Effect of co-exposure to ZnO-MTAP conjugates and UVA on caspase 
3/7 activity in OVCAR-3 cells. Cells were seeded into 96 well plates (1x105 cells 
/ml) and allowed to attach for 48 hours. ZnO-MTAP conjugates (10 µM) were 
then added and cells were subsequently exposed to UVA (9 kJ/m2). Caspase 3/7 
activity was measured at 3, 6, 12, or 24 hours later. An asterisk indicates a 





Figure 39. Hoechst 33342 and propidium iodide staining of OVCAR-3 cells co-
exposed ZnO-MTAP (10 µM) and UVA light (9 kJ/m2). At 0 (CTR), 3, 12 or 24 
hours after exposure, cells were incubated with Hoechst 33342 or propidium 
iodide as described in methods. Nuclear morphology was evaluated by 
fluorescence microscopy. Magnification: 0 and 3 hr (400 x); 12 and 24 hr (200 x). 
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TABLE 3. Summary of dark toxicity and phototoxicity of nanoparticle conjugates 




























IC50=3.5 mM - No - 
LaF3YbEr 
& Conjugates 
IC50> 1 mM 
IC50> 1 mM - - No 
NaF3YbEr 
& Conjugates 
IC50> 1 mM 
IC50> 1 mM - - No 
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Figure 40.  Effect of time after OVCAR-3 inoculation on on body weight in 
nude mice.Mice were inoculated with 1 x 107 (low dose), 1.8 x 107 (medium 
dose), or 2.4 x107 (high dose) OVCAR-3 cells in 300 µl of PBS (s.c.). One 
control mouse was injected with 300 µl of PBS (no tumor growth).  The mice 
were weighed every week. No apparent treatment-related body weight 




































Figure 41. Effect of dose of OVCAR-3 cells on solid tumor growth. Mice were 
inoculated with 1 x 107 (low dose), 1.8 x 107 (medium dose), or 2.4 x107 (high 
dose) OVCAR-3 cells in 300 ul of PBS (s.c.). One control mouse was injected 
with 300 µl of PBS (no tumor growth).  The sizes of the tumors were 
measured using a slide caliper every four days starting on day 56 post-





Figure 42. Mice at 10 weeks post-injection with OVCAR-3 tumor cells.  CTR-
control mouse inoculated with PBS.  Low-mouse injected with low-dose of 
OVCAR-3 cells.  Medium-mouse injected with the medium dose of OVCAR-3 
cells.  High-mouse inoculated with the high dose of OVCAR-3 cells.  Arrows 
indicate solid, subcutaneous masses of neoplastic cells that developed at the 











Figure 43. Mouse inoculated with the high dose of OVCAR-3 cells (s.c.) with skin 
removed from the mass to demonstrate a well-demarcated neoplastic mass 
within the subcutis in the inguinal region.  The neoplasm is attached to the 













Figure 44. Mouse inoculated with the medium dose of OVCAR-3 cells (i. p).  Note 
the white milky fluid composed of neoplastic cells in the peritoneal cavity 
surrounding the abdominal viscera.  No solid subcutaneous mass was present in 


















Figure 45.  Photomicrograph of a solid, subcutaneous, experimentally-induced 
ovarian carcinoma.  The mass is multinodular with neoplastic cells arranged in 
















Figure 46. Photomicrograph of cellular detail in solid subcutaneous tumor.  
Neoplastic cells exhibit moderate to marked aniocytosis and anisokaryosis; 


















Figure 47. Solid aggregate of neoplastic cells proliferating on the serosal surface 
of intraperitoneal fat in intraperitoneal tumor bearing mouse.  Solid intraperitoneal 
proliferations of cells were not grossly visible but were seen on microscopic 
examination.  Cellular morphology and architectural arrangement is similar to that 
of solid, subcutaneous tumors.  H&E stain  (200 x magnification). 
 95





Figure 48.  Photomicrograph of cytologic preparation of intraperitoneal fluid from 
an intraperitoneal tumor-bearing mouse.  Neoplastic cells are arranged in small 
clumps and clusters or occasionally as individual cells.  Cellular atypia appears 
more marked than in histopathologic sections of solid tumors.  Diff-quick stain  





























Figure 49. Effect of NAC on metabolic activity reduction by H2O2. HepG2 cells 
were seeded (2 x 105 cells/ml) on 96-well plates 24 hours prior to treatment with 
H2O2 (100 or 500 µM). Cells were pre-exposed to N-acetyl-cysteine (NAC, 5 mM) 
for 2 hours followed by addition of H2O2. Metabolic activity was measured 48 
hours later. An asterisk indicates a statistically significant difference compared to 




























Figure 50. Effect of DEM on metabolic activity by H2O2. HepG2 cells were seeded 
(2 x 105 cells/ml) on 96-well plates 24 hours prior to treatment with H2O2 (100 or 
500 µM). Cells were pre-exposed to diethyl maleate (DEM, 200 µM) for 2 hours 
and then exposed to H2O2. Metabolic activity was measured 48 hours later. An 
asterisk indicates a statistically significant difference compared to H2O2-only 

























Figure 51.  Effect of NAC on reactive oxygen species generation by H2O2. HepG2 
cells were seeded (2 x 105 cells/ml) on 96-well plates 24 hours prior to treatment 
with H2O2 (100 or 500 µM). Cells were pre-exposed to N-acetyl-cysteine (NAC, 5 
mM) for 2 hours. CM-H2DCFDA (10 µM) was added 30 minutes later. Reactive 
oxygen species were measured using a fluorescence microplate reader. An 
asterisk indicates a statistically significant difference compared to H2O2-only 



























Figure 52.  Effect of DEM on reactive oxygen species generation by H2O2. HepG2 
cells were seeded (2 x 105 cells/ml) on 96-well plates 24 hours prior to treatment 
with H2O2 (100 or 500 µM). Cells were pre-exposed to diethyl maleate (DEM, 200 
µM) for 2 hours. CM-H2DCFDA (10 µM) was added 30 minutes later. Reactive 
oxygen species were measured using a fluorescence microplate reader. An 
asterisk indicates a statistically significant difference compared to H2O2-only 
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Figure 53.  Effect of NAC on metabolic activity by CdTe and Cd(NO3)2. HepG2 
cells were seeded (2 x 105 cells/ml) on 96-well plates 24 hours prior to treatment 
with various concentrations of CdTe nanoparticles or Cd(NO3)2  . Cells were pre-
exposed to N-acetyl-cysteine (NAC, 5 mM) for 2 hours and then exposed to 
CdTe nanoparticles or Cd(NO3)2 . Metabolic activity was measured 24 hours 
later. An asterisk indicates a statistically significant difference compared to 
Cd(NO3)2 only (p < 0.05). A pound sign indicates a statistically significant 
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Figure 54.  Effect of diethyl maleate (DEM) on changes in metabolic activity 
following CdTe or Cd(NO3)2 exposure. HepG2 cells were seeded (2 x 10
5 cells/ml) 
on 96-well plates 24 hours prior to treatment with one of a range of 
concentrations of CdTe nanoparticles or Cd(NO3)2  . Cells were pre-exposed to 
DEM (200 µM for 2 hours) and then exposed to CdTe nanoparticles or Cd(NO3)2 . 
Metabolic activity was measured 24 hours later. An asterisk indicates a 
statistically significant difference compared to Cd(NO3)2 only (p < 0.05). A pound 


































Figure 55.  Effect of N-acetylcysteine (NAC) or diethyl maleate (DEM) on reactive 
oxygen species following exposure to CdTe nanoparticles. HepG2 cells were 
seeded (2 x 105 cells/ml) on 96-well plates 24 hours prior to treatment with either  
NAC (5 mM) or DEM (200 µM) for 2 hours. The cultures were then exposed to 
CdTe-Red nanoparticles (100 µM for 30 minutes). CM-H2DCFDA (10 µM) was 
added 30 minutes later. Reactive oxygen species were measured using a 
fluorescence microplate reader. An asterisk indicates a statistically significant 











































Figure 56.  Effect of N-acetyl cysteine (NAC) or diethyl maleate (DEM) on 
metabolic activity changes following nC60-AQ exposure. HepG2 cells were 
seeded (2 x 105 cells/ml) on 96-well plates 24 hours prior to treatment with NAC 
(5 mM for 2 hours) and then exposed to nC60-AQaggregates (3,300 ppm). 
Metabolic activity was measured 24 hours later. An asterisk indicates a 
statistically significant difference compared to control (p < 0.05). A pound sign 









































Figure 57.  Effect of N-acetyl cysteine (NAC) or diethyl maleate (DEM) on 
reactive oxygen species levels following exposure to nC60-AQ. HepG2 cells were 
seeded (2 x 105 cells/ml) on 96-well plates 24 hours prior to pre-exposure to 
either  NAC (5 mM) or DEM (200 µM) for 2 hours. The cultures were then 
exposed to nC60-AQ (3,300 ppm). CM-H2DCFDA (10 µM) was added 30 minutes 
later. Reactive oxygen species were measured using a fluorescence microplate 
reader. An asterisk indicates a statistically significant difference compared to 
control (p < 0.05). A pound sign indicates a statistically significant difference 
compared to nC60-AQonly  (p < 0.05).  
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Figure 58. Effect of nC60-AQ on caspase 3/7 activity. HepG2 cells were seeded (1 
x 105 cells/ml) on 96-well plates 24 hours prior to treatment with nC60-AQ (3,300 
ppm). Caspase 3/7 activity was measured at 2, 6, 12, or 24 hours later. An 















































Figure 59. Effect of N-acetyl cysteine (NAC) or diethyl maleate (DEM) on reactive 
oxygen species levels following exposure to ZnO-MTAP conjugates and UVA 
light. OVCAR-3 cells were seeded (1 x 105 cells/ml) on 96-well plates 48 hours 
prior to treatment with ZnO-MTAP conjugates (10 µM) under dark conditions. 
After 2 hours, cells were pre-exposed to either NAC *5 mM) or DEM (200 µM) for 
2 hours. The cultures were then exposed to 9 kJ/m2 UVA. CM-H2DCFDA (10 µM) 
was added 30 minutes later. Reactive oxygen species were measured using a 
fluorescence microplate reader. An asterisk indicates a statistically significant 
difference compared to control (p < 0.05). A pound sign indicates a statistically 














































Figure 60. Effect of N-acetyl cysteine (NAC) or diethyl maleate (DEM) on 
metabolic activity changes following exposure to ZnO-MTAP conjugates and 
UVA light. OVCAR-3 cells were seeded (1 x 105 cells/ml) on 96-well plates 48 
hours prior to treatment with ZnO-MTAP conjugates (10 µM) under dark 
conditions. After 2 hours, cells were pre-exposed to either  NAC (5 mM) or DEM 
(200 µM) for 2 hours. The cultures were then exposed to 9 kJ/m2 UVA. Metabolic 
activity was measured 24 hours later. An asterisk indicates a statistically 
significant difference compared to control (p < 0.05). A pound sign indicates a 



















































Figure 61. Effect of N-acetyl cysteine (NAC) or diethyl maleate (DEM) on 
caspase 3/7 activity following exposure to ZnO-MTAP conjugates and UVA light. 
OVCAR-3 cells were seeded (1 x 105 cells/ml) on 96-well plates 48 hours prior to 
treatment with ZnO-MTAP conjugates (10 µM) under dark conditions. After 2 
hours, cells were pre-exposed to either  NAC (5 mM) or DEM (200 µM) for 2 
hours. The cultures were then exposed to 9 kJ/m2 UVA. Caspase 3/7 activity was 
measured 3 hours later. An asterisk indicates a statistically significant difference 
compared to control (p < 0.05). A pound sign indicates a statistically significant 









Toxicity and Distribution of CdTe NPs in vitro and in vivo 
We demonstrated that CdTe nanoparticles can elicit concentration- and 
size-dependent cytotoxicity in human hepatoma HepG2 cells (Figure 5-7). Based 
on results obtained using the MTT assay for cell viability, different sized CdTe 
particles exhibited different cytotoxic potencies, with the smaller sized (green and 
yellow, 2-4 nm) nanoparticles being more potent than the larger sized (red, 6 nm) 
particles. 
Shiohara and colleagues reported that the cytotoxicity of CdSe 
nanoparticles could depend both on the relative size of the particles and the cell 
types exposed [42]. Our results suggest that size can be important in the 
cytotoxicity of CdTe nanoparticles in HepG2 cells. Lovric and coworkers [32] 
showed that different-sized CdTe nanoparticles exhibited differential subcellular 
distribution in rat pheochromocytoma (PC12) and N9 murine microglial cells, 
which could have a prominent role in their relative cytotoxic potential.  
           A previous study by Derfus and coworkers [31] suggested that cytotoxicity 
of CdSe was correlated with the liberation of Cd2+ from the nanoparticle lattice. 
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Using our synthetic methods, it was possible that some free Cd2+ remained in the 
nanoparticles “as prepared”. We therefore compared the cytotoxicity of CdTe-
Red nanoparticles as prepared with nanoparticles that were partially purified by 
methanol sedimentation. While the purified nanoparticles still exhibited relatively 
similar photophysical properties, their cytotoxicity was markedly reduced 
compared to the nanoparticles as prepared (Figure 8). This suggests that the 
nanoparticles as prepared may have some free cadmium or other contaminant 
that could increase the cytotoxicity of nanomaterials. 
We also estimated the stability of CdTe nanoparticles in culture. 
Aggregation of nanoparticles could have a dramatic effect on their 
physicochemical properties, and thus their utility in subsequent applications. 
There was apparent aggregation/agglomeration of the CdTe-Red nanoparticles 
over time (Figure 9). This aggregation appeared to be primarily extracellular, 
however, as similar clusters were noted when culture medium containing the 
nanoparticles was incubated in the absence of cells (data not shown). This could 
have importance in any potential applications of these or similar CdTe 
nanoparticles. If they cluster or aggregate under physiological conditions, this 
could impair their photophysical properties. It must be noted that these are 
relatively static conditions, and this aggregation may occur less readily under in 
vivo conditions, e.g., following systemic administration.  
Relatively few studies have evaluated in vivo toxicity of nanoparticles in 
animal models [25, 26, 28, 97, 98]. Previous studies suggest that these types of 
particles may be useful for in vivo imaging [46], potentially following intravenous 
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administration. We therefore evaluated the potential toxicity of CdTe-Red 
particles in rats following intravenous administration. Systemic administration of 
CdTe nanoparticles could potentially lead to nanoparticle distribution throughout 
the body however, and potentially elicit organ-specific responses. While there 
was a minimal (but significant) reduction in body weight 24 hours after dosing, 
few signs of overt toxicity were noted following intravenous administration of 
these particles. Histopathologic analysis of major organ systems found no 
treatment-related evidence of organ damage. Clinical chemistry indicators also 
suggested no evidence of liver or kidney damage or other changes in classical 
blood or urinary markers (although there was a trend for elevated blood alanine 
aminotransferase).  
Interestingly, locomotor activity was significantly decreased shortly after 
intravenous nanoparticle dosing, while activity levels were significantly increased 
24 hours after dosing (Figure 18). Motor activity is an integrative measure of 
nervous system function [99, 100]. Thus, the robust changes in motor activity 
noted following nanoparticle administration suggest an alteration in nervous 
system function is elicited by systemic CdTe-Red exposure. Some nanoparticles 
have been reported to pass the blood brain barrier following systemic 
administration [98]. Thus, under some conditions the CdTe-Red particles used 
herein may gain access to the central nervous system and disrupt integrated 
neural functions. On the other hand, free cadmium (as either contaminant or from 
degradation) could be responsible. The relative role of the nanoparticles 
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themselves, or Cd from the nanoparticles, in these motor effects requires further 
study.    
It should be noted that the exposure level in our in vivo study (2 µmol/kg, 
i.v.) is markedly lower than the exposure level studied inhalation administration of 
CdTe nanoparticles [28] .In contrast, our exposure level was higher than another 
study in mice using similar Cd-containing nanoparticles for biomedical imaging (6 
nmol/mouse, i.v.) [46]. Thus, at a level of exposure that could apparently be 
useful in biomedical (e.g., imaging) applications, few signs of overt toxicity were 
noted while an integrative measure of neurobehavioral function, locomotor 
activity, was affected by CdTe nanoparticle administration.  
Our studies demonstrate that CdTe nanoparticles can elicit cytotoxicity in 
HepG2 cells, and that size and purification (contaminants) may be important 
modifying factors. With in vivo exposure to CdTe-Red particles, few signs of overt 
toxicity or clinical chemistry indicators of adverse response were noted, but 
changes in locomotor activity were observed. These studies provide a framework 
for further studies to characterize the toxic potential of CdTe-containing 
semiconductor nanoparticles. 
As noted above, understanding the mechanism of toxicity for synthetic 
nanomaterials can be useful in developing safer materials or handling 
procedures, and potentially therapeutic or protective measures to prevent 
intoxication. To evaluate the possible mechanism of cytotoxicity elicited by CdTe 
nanoparticles, we evaluated indicators of apoptosis including Hoechst 33342 
staining, caspase induction and DNA fragmentation. Nuclear condensation was 
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elicited after 24 hours incubation with CdTe-red particles, but not earlier (i.e., at 4 
hours after exposure, Figure 13). Similarly, caspase 3/7 activity was induced by 
CdTe-red particles in a dose- and time-dependent manner (Figures 14 and 15). 
In addition, the hallmark of apoptosis, DNA fragmentation was noted in cells after 
48 hours exposure to CdTe-Red nanoparticles (Figure 16). Thus, several 
endpoints suggested that CdTe nanomaterials may induce apoptosis in HepG2 
cells.  
It is known that free cadmium can induce the expression of the heavy 
metal-binding protein, metallothionein, in HepG2 cells. Cadmium may exist as 
free metal in preparations of Cd-containing nanoparticles, and it may be 
produced in such preparations during storage or through environmental/biological 
degradation. We therefore evaluated metallothionein expression in HepG2 cells 
exposed to CdTe-Red nanoparticles, using cadmium (0.2 µM) as a positive 
control. Metallothionein mRNA was increased by CdTe-Red nanoparticles at 
lower concentrations (0.2 - 1µM) but decreased at higher concentrations (20 - 
100 µM). This biphasic dose-response curve may indicate that low levels of 
cadmium in the nanoparticle preparation indeed increased expression of 
metallothionein, but that higher levels actually decreased its expression. 
Interestingly, metallothionein protein levels were lower in CdTe treated cells 
(Figure 18). This may indicate that cytotoxicity can be elicited by the CdTe 
nanoparticle themselves, as well as by free cadmium.  
Discussion of the potential toxicity of semiconductor nanoparticles can be 
confounded by the high diversity of such nanomaterials being synthesized. It was 
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reported that the cytotoxicity of CdSe nanoparticles correlated with the liberation 
of free Cd2+ ions [31]. Recent studies reported that the cytotoxicity of CdSe 
nanoparticles depended both on the relative size of the particles and the types of 
target cells [42]. It has also been reported that marked cytotoxicity occurs in 
PC12 and N9 cells exposed to concentrations as low as 10 µg/ml CdSe [32]. Cell 
death was associated with chromatin condensation and membrane alterations 
and was more prominent with smaller (about 2 nm) than larger (about 5 nm) 
nanoparticles [32]. There is also evidence that surface chemistry, in particular 
surface characteristics that impair particle aggregation, has an important role in 
the cytotoxicity of nanoparticles [101]. Characterization of the surface and other 
physical properties is obviously a critical factor in the accurate assessment of 
biological reactivity/toxic potential. But even if nanomaterials being evaluated 
have been completely and carefully characterized, there is still the possibility of 
alteration or degradation of the materials once in the biological system(s).  
In the study of inhaled particles, surface area and particle size played 
important roles in toxicity [25, 26, 97]. Furthermore, movement of the particles 
from the alveoli to interstitial spaces may have been facilitated by degradation of 
the particles into smaller units within the tissues, thus the transformation of 
nanomaterials inside the body is a potential concern [102, 103]. In a pulmonary 
toxicity study, CdTe nanoparticles elicited extensive pulmonary damage 
(expressed as increased lung weight, decreased macrophages, increased lactate 
dehydrogenase, increased protein content in bronchoalveolar fluid, terminal 
bronchiolar necrosis with fibrin exudates, and type II cell hyperplasia) [28, 104].  
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As CdTe nanoparticles are fine-tunable and will emit stable fluorescence 
at specific excitation wavelengths, confocal microcopy can potentially be a very 
useful tool for evaluating their localization. Transmission electron microscopy can 
also be useful for determining tissue distribution. To understand mechanisms of 
toxicity and thereby prevent or decrease the potential toxicity of these particles,. 
In addition, distribution studies of nanoparticles in vivo can help determine 
whether the particles are effectively distributed and accumulate in tissues, or 
effectively eliminated. Such findings will be important in further development and 
application of these types of materials.  
As shown above (Figure 7), we observed size-dependent cytotoxicity of 
CdTe nanoparticles, i.e., 2 nm CdTe particles were more potent at decreasing 
cell viability in HepG2 cells than 6 nm CdTe nanoparticles [105]. The results 
suggested that CdTe-Red may be transported into cells through the membrane 
into the cytoplasm, and possibly into the nucleus, in a size- and time-dependent 
manner. The apparent differential distribution of the different sized particles 
suggests that these nanoparticles may form complexes with proteins and 
possibly enter via endocytic pathways [106].  
Our results are the first to suggest neurotoxic potential of CdTe 
nanoparticles following systemic administration (Figures 21 and 22). Cadmium 
was detected in both liver and brain following systemic dosing (Figure 24-27). 
However, the cadmium as measured (by atomic absorption) could be from intact 
nanoparticles entering the tissues, or from free cadmium as contaminant or 
degradation product. We used x-ray analysis to determine if both cadmium and 
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telluride could be detected in the same scan. Indeed, x-ray analysis suggested 
that both cadmium and telluride were together in the tissue.To our knowledge, 
this is the first demonstration of semiconductor nanoparticles in tissues by 
transmission electron microscopy using x-ray analysis. CdTe nanoparticles may 
therefore enter tissues (including brain) as intact nanomaterials following 
systemic administration.  On the other hand, free cadmium and telluride could 
conceivably distribute into tissues and be detected in the same tissue section.   
Cytotoxicity of nC60 in HepG2 Cells 
The chemical and physical properties of nC60 made by different methods 
could lead to differential biological effects. These differential properties include 
size, morphology, charge and hydrophobicity [91, 107]. Therefore, we compared 
the cytotoxicity of nC60 synthesized by four different methods, i.e., solvent 
extraction using tetrahydrofuran (THF), solvent extraction using 
toluene/tetrahydrofuran/acetone (TTA), sonication with toluene extraction (SON), 
and prolonged stirring in aqueous medium (AQ). We found marked differences in 
cytotoxicity with nC60 prepared by the different methods (Figure 24). Essentially, 
nC60 synthesized by extraction with TTA appeared more cytotoxic than the other 
three types of nC60. These differences may not be due to the aggregates 
themselves, but due to residual organic solvent that was not removed during the 
preparation (Ausman, unpublished data). Others have suggested that the toxic 
effects of nC60  prepared with organic solvents may be due to residual solvent in 
the preparation [41].  
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To obtain more purified samples  of nC60, samples of aggregates prepared 
by the four different methods were extensively concentrated by flash evaporation. 
Following such purification, none of the preparations (up to 3,300 ppm) elicited 
cytotoxicity in HepG2 cells (data not shown). We subsequently reevaluated these 
same samples after one month in storage. Interestingly, the AQ, THF and TTA 
nC60 samples all affected cell viability (Figure 29), and cytotoxicity of nC60-AQwas 
concentration–dependent (Figure 30). Organic solvent retained in the nC60 
prepared by some methods may be important under some conditions.  The 
toxicity ofnC60 may not, however be only due to residual solvent. As previously 
noted with characterizations such as CdTe nanoparticles, surface properties or or 
size can potentially contribute to the toxicity of nanomaterials.  
Although the cytotoxic mechanism of nC60-AQ is unknown, it is possible 
that an epoxide can form at surface sites with prolonged exposure to oxygen 
(air), which could in turn change the physical properties and reactivities of the 
nanomaterials (e.g., leading to agglomeration, K. Ausman, personal 
communication). In addition, preparation of nC60-AQ requires air (personal 
communication, K. Ausman); therefore oxygen may influence the the toxic 
potential of nC60-AQ by facilitating oxidative mechanisms. Previous studies have 
shown that nC60-THF induced cytotoxicity through oxidative stress, leading to 
lipid peroxidation in human dermal fibroblasts, human HepG2 cells, and human 
astrocytes [38]. Our studies using a reactive oxygen species probe demonstrated 
increased levels of reactive oxygen species in a time-dependent manner after 
exposure to nC60-AQ. Furthermore, ROS and cytotoxicity of nC60 were modulated 
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by pre-exposure to either NAC or DEM (Figures 56 and 57), providing further 
evidence of oxidative stress mechanisms in the toxicity of nC60. Further studies 
could attempt to modulate the degree of possible oxygenation (epoxidation) of 
nC60 to determine its relative contribution to the toxicity of nC60.  
Phototoxicity and Distribution of NP Conjugates in vitro 
Nanomaterials have numerous potential applications for targeted drug 
therapy [81-83]. We evaluated the potential phototoxicity of ZnO-MTAP 
conjugates using UVA irradiation as a chemotherapeutic approach against 
ovarian cancer cells. The cytotoxic potency of a photosensitizer depends directly 
on the amount of reactive oxygen species it generates [108]. Therefore, we 
measured reactive oxygen species produced by the ZnO-MTAP nanoparticle 
conjugates under both dark and light conditions using the fluorescent probe, CM-
H2DCFDA. Essentially no evidence of ROS generation was noted with ZnO-
MTAP conjugates under dark conditions, while concentration- and irradiation 
dose-dependent effects were noted with UVA irradiation (Figure 33). Thus, these 
nanoparticle conjugates appeared effective at coupling irradiation with the 
luminescence of the particle to produce reactive species.  
To evaluate if these conjugates could accumulate in cells, OVCAR-3 cells 
were incubated with ZnO-MTAP conjugates (10 µM) for 4 hours, and then 
evaluated by confocal microscopy. Indeed, conjugates appeared to accumulate 
in the cytosol of OVCAR-3 cells (Figure 34). A number of studies suggest that the 
uptake of various types of nanoparticles is mediated by an endocytic pathway 
[109-111]. Since reactive oxygen species typically have a short half-life, 
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internalization of nanoparticle conjugates is likely a critically important factor in 
effective photodynamic therapy for targeting specific cells. 
Our studies demonstrated that ZnO-MTAP conjugates can be activated by 
UVA light to generate reactive oxygen species and to decrease cell viability in 
human OVCAR-3 ovarian cancer cells in vitro. In self-lighting photodynamic 
therapy, the emission wavelength of the nanoparticle should be matched to the 
absorbance wavelength of the photosensitizer for effective coupling. We reported 
that ZnO nanoparticles can effectively transfer energy to MTAP (about 83%) 
under UVA illumination after conjugation [86]. For safe photodynamic therapy, 
the photosensitizer should be inactive under dark conditions. Indeed, the ZnO-
MTAP conjugates generated essentially no reactive oxygen species in the 
absence of irradiation (Figure 33). Considerable evidence suggests that 
mitochondrial function can be targeted in photodynamic therapy approaches 
[112-114]. We evaluated cell viability by the MTT assay, which relies on 
mitochondrial enzymes to reduce the formazan dye product. The reduced activity 
in the MTT assay in cells exposed to ZnO-MTAP conjugates in the presence of 
UVA suggests that the conjugates are photoactivated to generate reactive 
oxygen species, leading to mitochondrial damage and reduced cell viability. 
Thus, these conjugates demonstrate the proof of concept for self lighting 
photodynamic therapy using ZnO nanoparticles and UVA light.  
It should be noted that any form of irradiation can potentially have adverse 
effects on cells and tissues [115, 116]. UVA (320-400 nm) is less harmful than 
either UVB (290-320 nm) or UVC (200-290 nm) due to its relatively low energy. 
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In clinical applications, UVA and a photosensitizer have been successfully used 
to treat skin diseases such as eczema and psoriasis [117]. In our studies, UVA 
alone at the highest exposure tested (36 kJ/m2) led to reduced OVCAR-3 cell 
viability. We used 9 kJ/m2, a subcytotoxic (Figurer 36) and biologically relevant 
level of exposure, to evaluate the potential phototoxicity of these conjugates 
[118] . While neither UVA nor the ZnO nanoparticles alone elicited cytotoxicity, 
the combination was highly effective at reducing cell viability (Figure 37).  
There are two basic modes of cell death, i.e., necrosis and apoptosis. It 
has been reported that photoactivation of hematoporphyrin monomethyl ether (a 
porphyrin-derivative photosensitizer similar to MTAP) induced mainly necrosis in 
NuTu-19 ovarian cancer cells [119]. Wyld and coworkers suggested cell death in 
photodynamic therapy could occur through either necrosis or apoptosis, 
depending on the target cell type and various dosing conditions [120]. Our 
studies suggest that both apoptosis and necrosis can be elicited by 
photoactivation of ZnO-MTAP conjugates (Figure 39).  
Nanotechnology applications for photodynamic therapy can utilize the 
advantage of size and surface properties of the materials for drug delivery [81-
83]. Sunscreens containing nanoscale titanium dioxide or zinc oxide particles can 
effectively block UV light [4]. It has been reported that the phototoxicity of TiO2 
nanoparticles was increased by UVA light, with toxicity being related to 
generation of hydroxyl radical [121, 122]. We focused on the application of self-
lighting optical properties of the ZnO nanoparticles in photodynamic therapy. We 
hypothesized that luminescence of ZnO particles elicited by UVA or other 
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irradiation could activate the photosensitizer MTAP, which would in turn transfer 
energy to molecular oxygen, followed by generation of reactive oxygen species 
and targeted cell destruction. The data provided indicate that these conjugates 
can indeed generate reactive oxygen species in the presence of UVA light that 
can in turn reduce tumor cell viability. Although the approach is effective with 
ovarian cancer cells in vitro, translation into whole animal applications is 
challenging. Nanoparticle conjugates may bind to tissue or blood proteins, 
potentially influencing their cellular uptake or tissue targeting. The optical 
properties of the nanoparticle conjugates could be modified in vivo. A number of 
studies suggest that the toxicity of nanomaterials may be markedly different in 
cellular and whole animal models [39, 105]. Thus, transitioning an approach from 
cell culture to whole animal has a number of potential pitfalls.  
In our model of self-lighting photodynamic therapy, the irradiation source 
is perhaps the most challenging problem. X-ray irradiation is a convenient vector 
for photodynamic approach. Preliminary studies had indicated that X-ray 
irradiation could activate ZnO-MTAP conjugates in the solid state (data now 
shown). Thus, our initial efforts were directed at using x-irradiation to activate the 
conjugates in cells. Unfortunately, there was no apparent interaction between 
ZnO-MTAP conjugates and x-irradiation (data not shown). Thus, further work is 
needed to develop nanoparticle conjugates that can be activated by radiation 
sources that will allow deep tissue penetration. Our findings illustrate, however 
the overall potential for te approach of using luminescent nanoparticles 
conjugated with a photosensitizer in photodynamic therapy. 
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The ultimate goal of this project was to evaluate the phototoxicity of the 
nanoparticle conjugates in vivo. For this approach, the animal ovarian tumor 
model was necessary. We simultaneously developed a whole animal model of 
human ovarian cancer by inoculating OVCAR-3 cells into nude mice while we 
were studying the in vitro effects of the conjugates. We have shown that tumor 
growth is dose–related following subcutaneous inoculation, with solid tumor 
being grossly visible within 56 days after inoculation. The inoculated mice 
survived at least to 72 days after inoculation, without significant body weight 
change. An inoculation dose of 2.4 X 107cells/mouse appeared suitable for 
further studies. The development of the tumor was confirmed by necropsy and 
histopathological evaluation. We therefore demonstrated conditions for 
establishing a consistent ovarian tumor model in nude mice that could be used in 
future pharmacological evaluations of nanoparticle-conjugate photodynamic 
therapy. 
Oxidative Stress as a Mechanism of Nanotoxicity 
While novel engineered nanomaterials bring exciting applications and 
advances in technology, they also pose new concerns for regulation and safety 
evaluation. Tons of different nanoscale materials are potentially going to be 
released into the environment, thus risk assessment of nanomaterials will be 
increasingly needed. Development of biomarkers of nanotoxicity could be 
beneficial in the assessment of risk. Indicators of oxidative stress may be 
important biomarkers of toxicity for selected nanomaterials. 
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If toxicity of nanomaterials is elicited by oxidative stress, that toxicity 
should be reduced by enhancing intracellular antioxidant status. We studied this 
in vitro by pre-treating cells with N-acetyl-cysteine (NAC), precursor of 
glutathione, prior to nanomaterial challenge. On the other hand, ROS-mediated 
cytotoxicity should be increased by reducing intracellular antioxidant levels. To 
study this possibility, we pre-treated cells with the glutathione depletor diethyl 
maleate (DEM) before exposing the cells to the nanomaterials. Through these 
approaches, we were able to define whether ROS likely played a role in the 
toxicity of the selected nanomaterials under study.  
We first evaluated whether CdTe nanoparticles can mediate toxicity 
through oxidative mechanisms using these approaches. It is well known that free 
cadmium can induce oxidative stress [93, 94, 123]. In our studies, however, the 
toxicity of cadmium-containing nanoparticles did not appear to be mediated 
through oxidative stress (Figure 53-55). Although the toxicity of CdTe 
nanoparticles was reduced by pre-exposure to NAC, this is likely because of 
direct chemical-chemical interactions (i.e., the NAC bound directly to free 
cadmium or possibly the CdTe nanomaterials). These results generally agree 
with a previous study showing that NAC (4 mM) could block cytotoxicity of CdTe-
green nanoparticles [32]. Studies in which the ROS probe was used suggested 
however, that CdTe-induced caspase activation was not dependent on oxidative 
stress. Shi and coworkers reported that CdTe nanoparticles generated ROS in 
the presence of meso-tetra(4-sulfonatophenyl)porphine dihydrochloride (TSPP) 
with photoactivation, but no ROS were detected when the nanoparticles were 
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illuminated without TSPP [124]. It should be stressed that cells in all of our 
studies on the cytotoxicity of CdTe nanoparticles were exposed under dark 
conditions. Thus, while NAC appears to protect from CdTe cytotoxicity, it does 
not appear to be due to reducing the amount of ROS produced.  
We then evaluated the possible role of ROS in nC60 toxicity. The nC60-AQ 
increased ROS levels in a time-dependent manner (Figure 32). Furthermore, the 
elevation in ROS was blocked by pre-exposure to NAC (Figure 57). Moreover, 
nC60-AQ induced cytotoxicity was reduced by pre-exposure to NAC and 
increased by pre-exposure to DEM (Figure 56). These findings suggest that the 
toxicity of nC60 is indeed mediated through oxidative stress. As mentioned before, 
purity can be an important factor in the biological reactivity of nanomaterials. 
Although a number of studies suggest a role for oxidative stress in the toxicity of 
nC60 [38, 40], it should be noted that these nC60 materials were typically 
synthesized using organic solvents. Recently, Henry and coworkers did not 
detect THF itself but did find gamma-butyrolactone, an oxidation product of THF, 
in nC60-THF preparations, suggesting a possible role for this degradation product  
in the toxicity of these types of nanomaterials [125]. Unpublished findings also 
suggest that during aerobic storage of nC60, oxygen may oxygenate the surface 
and alter reactivity. Our studies with nC60–AQ showing apparent increased 
cytotoxic potential following storage support this possibility. 
Apoptosis mediated through the caspase(s) pathway has been reported in 
a number of studies involving photodynamic therapy [126-130]. Oxidative stress 
can be an important mechanism in photodynamic therapy [95, 96]. In our studies, 
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we demonstrated that phototoxicity of ZnO-MTAP conjugates in the presence of 
UVA light involved caspase 3 activation and oxidative stress. While UVA light 
alone can cause oxidative stress with higher exposures (40 -90 kJ/ m2) [131, 
132], , the exposure level in our studies (9 kJ/m2) did not induce oxidative stress 
(Figure 33).  
In summary, both nC60 and ZnO-MTAP conjugates/UVA appeared to elicit 
cytotoxicity through ROS and oxidative stress. In contrast, the cytotoxicity of 
CdTe nanoparticles did not appear to be mediated through this mechanism.  
 It is clear from these studies that the toxicity of nanomaterials is 
dependent on numerous factors including the general type of nanostructure, the 
chemical constituents, contaminants, degradation products, surface 
modifications, and possibly numerous other characteristics. Characterization of 
the sample being investigated is paramount in understanding its toxic potential. 
Even if well characterized, however, there is still the possibility of change in the 
sample over time during storage, for environmental degradation, or for biological 
transformation within a living organism or ecosystem.  
These studies demonstrate some approaches that can be taken to 
evaluate the toxicity of synthetic nanomaterials, or for that fact any chemical that 
has relatively little information available about its toxic potential. While in vitro 
studies are relatively straightforward, nanomaterials have some characteristics 
that may make them particularly difficult to study in whole animals. One such 
characteristic is agglomeration. If a nanomaterial is effective in a particular 
application by nature of its size, and multiple nanomaterials aggregate or 
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agglomerate in biological systems, this will likely change its function. We noted 
the apparent aggregation of CdTe nanoparticles in studies with HepG2 cells. 
Thus, even if a nanomaterial is exceedingly well characterized before use in a 
biological system, it may change by this process. Obviously, it is unclear what 
clustering or agglomeration of nanomaterials means for toxicity potential across 
different types of nanomaterials. There are many unknowns regarding the 
biological reactivity and toxic potential of the plethora of different types of 
nanomaterials known, and the likely greater number to be produced in the future. 
Approaches such as those outlined in this study can lay the groundwork, 
however, for understanding the biological effects of different types of 















1. Toxicity of engineered nanomaterials is an open question, to be evaluated 
on a case-by-case basis. 
2. CdTe nanoparticles elicited cytotoxicity in HepG2 cells in vitro. No 
apparent hepatotoxicity was noted following in vivo exposure, however. 
3. Surface properties contribute to nanotoxicity. The size of CdTe 
nanoparticles and the oxidative potential of nC60 play an important role in 
their toxicity. 
4. Composition/element of the nanomaterials is also important for their 
toxicity potential. 
5. Purity of the nanomaterials (free metal, organic solvent) can be important. 
The full characterization of a nanomaterial preparation is essential for 
understanding its biological effects. 
6. Indicators of oxidative stress may serve as biomarkers in risk assessment 
of some nanomaterials. 
7. CdTe-induced cytotoxicity is size- and concentration-dependent, involving 
caspase 3 activation, DNA fragmentation and metallothionein induction, 
but apparently not mediated by oxidative stress. 
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8. CdTe alters motor activity following in vivo dosing, suggesting the possible 
disruption of nervous system function. 
9. Subcellular distribution of CdTe is size- and time- dependent. Atomic 
absorption spectrometry and x-ray analysis of transmission electron 
micrographs suggested  CdTe nanoparticles may distribute into tissues 
following systemic administration.  
10. nC60-AQ appear to elicit cytotoxicity through ROS and oxidative stress. 
11. ZnO-MTAP conjugates elicit selective phototoxicity, apparently involving 
both apoptosis and necrosis. Apoptosis appeared mediated by caspase(s) 
and through ROS and oxidative stress. 
12. An ovarian tumor model was successfully developed in nude mice by 
subcutaneous inoculation of  NIH: OVCAR-3 cells. This model could be 
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Scope and Method of Study:  
           The toxicity of selected synthetic nanomaterials was studied using both in 
vitro and in vivo approaches. The toxicity of inorganic CdTe nanoparticles 
was first evaluated using both human HepG2 cells in vitro and systemic 
exposure in male rats in vivo. Cytotoxicity of organic fullerene aggregates 
was also evaluated in HepG2 cells. The potential utility of zinc oxide 
nanomaterials conjugated to a porphyrin derivative in the photodynamic 
therapy of ovarian cancer cells in vitro was evaluated. Mechanistic studies 
to determine the role of reactive oxygen species and oxidative stress in 
the cytotoxicity of all of these nanomaterials were conducted. A number of 
techniques/approaches including neurobehavioral assessments, 
biochemical assays, real-time PCR, western blotting, and both electron 
and confocal microscopy were used to address the biological 
consequences of nanomaterial exposure. 
 
Findings and Conclusions:   
1. CdTe nanoparticle-induced cytotoxicity is size- and concentration-
dependent, involving caspase(s) activation, DNA fragmentation and 
metallothionein induction, but apparently not oxidative stress. 
2. CdTe altered motor activity following in vivo dosing, suggesting possible 
disruption of nervous system function. 
3. Subcellular distribution of CdTe was size- and time- dependent. 
4. Intact CdTe nanoparticles appeared to distribute into tissues following 
intravenous administration in rats. 
5. Surface properties, size, chemical composition, and purity of 
nanomaterial preparations can all contribute to nanotoxicity.  
6. Fullerene aggregates appeared to elicit cytotoxicity via oxidative stress.  
7. ZnO conjugates elicited selective phototoxicity involving both apoptosis 
and necrosis, mediated by caspase(s) activation and oxidative stress. 
 
